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ABSTRACT 
 
NtdB is an enzyme encoded within the ntd operon in Bacillus subtilis. This 
operon is reported to contain a complete set of genes necessary for the biosynthesis of 
3,3'-neotrehalosadiamine (NTD), a compound composed of two kanosamine subunits 
linked together by a 1,1'-(α,β)-linkage. Both NTD and kanosamine have reported 
antibiotic properties. The function of NtdB has been a matter of speculation, but has 
never been investigated in vitro. Using a phosphate assay and an array of substrates, 
NtdB was determined to be a phosphatase, specific to kanosamine-6-phosphate (K6P) 
(kcat = 32 ± 1 s
-1
, Km = 93 ± 7 µM). Site-directed mutagenesis of amino acid residues in 
the core and the cap domains of the enzyme identified residues important for the catalytic 
reaction and substrate specificity. These mutations confirmed the presence of four motifs, 
characteristic of members of the haloacid dehalogenase (HAD) superfamily, and allowed 
identification of the substrate binding site of the enzyme. KabB, a homologue of NtdB 
from Bacillus cereus, showed notably lower activity with K6P than NtdB. This research 
defines the role of NtdB as a specific K6P phosphatase and challenges the previously 
reported NTD biosynthesis pathway by demonstrating a novel pathway for the production 
of the antibiotic kanosamine. 
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1 INTRODUCTION 
1.1 Discovering new antibiotics, such as 3,3'-neotrehalosadiamine 
 
In 1986, in the course of a screening for aminoglycoside antibiotics, a new 
aminosugar antibiotic produced by Bacillus sp., 3,3'-neotrehalosadiamine (NTD), was 
reported.
1
 Using a paper disc assay, it was shown to inhibit the growth of Staphylococcus 
aureus and Klebsiella pneumoniae.
2
 During the last 60 years, S. aureus (both hospital and 
community acquired) has developed resistance not only to methicillin, but also to 
oxacillin (replacement to methicillin) and other beta-lactams.
3
 Some methicillin-resistant 
strains of S. aureus (MRSA) are also becoming resistant to erythromycin, ciprofloxacin, 
gentamicin, neomycin, trimethoprim, and tetracycline.
4
 Similarly, new strains of 
carbapenem-resistant K. pneumonia (CRKP) have started appearing in hospitals all over 
the world, with no efficient antibiotics to fight them.
5,6
 Therefore, in parallel with 
research on the mechanisms of resistance of these bacteria, the investigation of new 
potential antibiotics, such as NTD, is essential (Figure 1.1). 
 
NTD is composed of two kanosamine subunits, linked together by a α,β-1,1'-
linkage (Figure 1.1).
2 This type of α,β-linkage is related to neotrehaloses and, to this day, 
NTD is the only known neotrehalose composed of two aminosugars. NTD was first 
isolated as part of a screening program to obtain novel aminoglycoside antibiotics.
2
 It was 
reported to be produced naturally by B. pumilis
2
 and B. circulans
7
 as well as a rifampicin 
resistant mutant of B. subtilis.
8  
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Figure 1.1: Structure of aminoglycoside antibiotics 
 
 It is not surprising that NTD exhibits antibiotic properties. Kanosamine has 
antibacterial and antifungal activity,
9, 10
 and is reported to inhibit bacterial cell walls 
synthesis.
11
 The kanosamine subunit is also found in many other antibiotics, such as 
kanamycin and α,α-3-trehalosamine (Figure 1.1).12,13 
 
1.2 ntd operon 
 
A Rif
r
rpoB5 mutation in B. subtilis has been shown to activate a dormant ability to 
produce NTD.
8
 The genes involved in the production of this antibiotic were isolated 
using transposon mutagenesis, which consisted of the insertion of a vector which 
interrupted the gene activity. Three genes were identified, ntdA, ntdB, and ntdC, and their 
role in the biosynthesis of NTD was confirmed by cloning them into pUC18 and 
expressing them in a bacteria not affected by NTD, Escherichia coli (E. coli), under the 
 3 
 
control of a lac promoter. The unusual production of NTD by E. coli was confirmed by 
ESI-MS analysis.
8
 
 
Further investigation revealed that the ntd operon contains a total of 5 genes. The 
first is a transcriptional regulator, ntdR, which is encoded in reverse compared to the 
others genes of the operon. The mechanism obeyed by this regulator has yet to be 
understood, but preliminary studies seem to indicate that it may function as an 
autoinducer.
14
 This gene is followed by ntdA, ntdB, and ntdC. There is a sequence 
overlap of ntdA and ntdB, such that the beginning of ntdB is encoded in the end of ntdA 
by 29 base pairs. The last gene in the operon is glcP, which encodes for a 
glucose/mannose:H
+
 symport permease.
8, 14
  
 
1.3 End product of the operon 
 
1.3.1 First hypothesis: NTD 
 
To understand the production of NTD by the ntd operon, study of the three genes, 
ntdABC, was undertaken. According to their amino acid sequence, NtdA was suggested 
to be a pyridoxal phosphate (PLP)-dependent aminotransferase, NtdB a hydrolase, and 
NtdC a nicotinamide adenine dinucleotide (NAD
+
) dependent dehydrogenase.
8
 Based on 
the proposed functions of the three enzymes encoded by the ntdABC operon, an NTD 
biosynthetic pathway was initially proposed (Scheme 1.1). This hypothesis was tested by 
Palmer et al.
15, 16
   
 
Scheme 1.1: The biosynthetic pathway of ntdABC operon, producing NTD as a final product. 
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The kinetics of NtdC were evaluated and showed that glucose-6-phosphate (G6P) 
was a good substrate for this enzyme, with a kcat of 4.0 ± 0.1 s
-1
 and a Km of 13 ± 1 µM.
15
 
NtdA was characterized as a Glu-dependent aminotransferase
17
, and its crystal structure 
was solved in its three main forms: with its cofactor, PLP, with pyridoxamine phosphate 
(PMP), and with the proposed product, kanosamine-6-phosphate (K6P).
16,18
 It  was also 
shown to be specific for α-D-K6P in the reverse direction of the reaction shown in 
Scheme 1.1.
18
 The proposed conversion of G6P and K6P by NtdC and NtdA based on 
Scheme 1.1, was confirmed by HPLC, and a short lived intermediate was observed by 
UV spectrophotometry at 310 nm.
17
  
 
 The assignment of NtdB in Scheme 1.1 presumed that the enzyme was 
responsible for the α,β-glycosidic bond found in NTD. Usually, such a bond is formed 
with a glycosyltransferase and a nucleotidyl sugar, as can be seen in Scheme 1.2 in which 
trehalose-6-phosphate synthase (TPS) uses G6P and uridine diphosphate (UDP)- or 
guanosine diphosphate (GDP)-glucose to form trehalose-6-phosphate.
19
 
Dephosphorylation occurs in the second step, by the action of trehalose-6-phosphate 
phosphatase (TPP). This pathway is not consistent with the results and observations 
found for the NtdA and NtdC enzymes. Different hypotheses therefore arise: NtdB is a 
unique kind of enzyme, catalyzing a novel type of reaction; the ntdABC operon is 
incomplete, some genes such as a glycosyltransferase are missing; the ntdABC operon 
has a different end product than NTD. This last hypothesis is further discussed in the next 
section.    
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Scheme 1.2: The catalytic pathway of trehalose using G6P and UDP/GDP-glucose as initial 
substrates. 
 
1.3.2 Second hypothesis: Kanosamine 
Since 1996, it was known that B. cereus produces the antibiotic kanosamine.
9
 
Thirteen years later, the kab operon from B. cereus was identified as a potential operon 
containing the genes necessary for the production of kanosamine. A sequence alignment 
comparing KabA, KabB, and KabC with NtdA, NtdB, and NtdC was performed and 
revealed an identity of 57%, 55% and 57% respectively (Figure 1.2-1.4). This high 
sequence identity between both sets of proteins suggests that the ntdABC operon may 
encode for kanosamine production instead of NTD. 
 
 6 
 
 
Figure 1.2: Sequence alignment of NtdA and KabA.  
Generated with ClustalW
20
, using the Blosum scoring matrix
21
: opening gap penality = 10; extending gap 
penality = 0.20; distance gap penality = 5. Image was created by ESPript V2.2
22
. The amino acids 
represented with white letters are identical, while red letters denote similar residues. 
 
 
 
 7 
 
 
F
ig
u
re
 1
.3
: 
S
eq
u
en
ce
 a
li
g
n
m
en
t 
o
f 
N
td
B
 a
n
d
 K
a
b
B
. 
 
G
en
er
at
ed
 
w
it
h
 
C
lu
st
a
lW
2
0
, 
u
si
n
g
 
th
e 
B
lo
su
m
 
sc
o
ri
n
g
 
m
at
ri
x
2
1
: 
o
p
en
in
g
 g
ap
 p
en
al
it
y
 =
 1
0
; 
e
x
te
n
d
in
g
 g
ap
 p
en
a
li
ty
 =
 0
.2
0
; 
d
is
ta
n
ce
 
g
ap
 p
en
al
it
y
 =
 5
. 
Im
a
g
e 
w
as
 c
re
at
ed
 b
y
 E
S
P
ri
p
t 
V
2
.2
2
2
. 
T
h
e 
a
m
in
o
 
ac
id
s 
re
p
re
se
n
te
d
 w
it
h
 w
h
it
e 
le
tt
er
s 
ar
e 
id
en
ti
ca
l,
 w
h
il
e 
re
d
 l
et
te
rs
 
d
en
o
te
 s
im
il
ar
 r
es
id
u
es
. 
F
ig
u
re
 1
.4
: 
S
eq
u
en
ce
 a
li
g
n
m
en
t 
o
f 
N
td
C
 a
n
d
 K
a
b
C
. 
 
G
en
er
at
ed
 w
it
h
 C
lu
st
a
lW
2
0
, 
u
si
n
g
 t
h
e 
B
lo
su
m
 s
co
ri
n
g
 m
at
ri
x
2
1
: 
o
p
en
in
g
 
g
ap
 
p
en
al
it
y
 
=
 
1
0
; 
ex
te
n
d
in
g
 
g
ap
 
p
en
a
li
ty
 
=
 
0
.2
0
; 
d
is
ta
n
ce
 g
ap
 p
en
al
it
y
 =
 5
. 
Im
a
g
e 
w
as
 c
re
at
ed
 b
y
 E
S
P
ri
p
t 
V
2
.2
2
2
. 
T
h
e 
am
in
o
 
ac
id
s 
re
p
re
se
n
te
d
 
w
it
h
 
w
h
it
e
 
le
tt
er
s 
ar
e 
id
e
n
ti
ca
l,
 
w
h
il
e 
re
d
 l
et
te
rs
 d
en
o
te
 s
im
il
a
r 
re
si
d
u
es
. 
 8 
 
 
 
 
Scheme 1.3: The proposed biosynthetic pathway of kanosamine by the kabABC operon from B. 
cereus.
23
 
 
Kevany et al. proposed a scheme for the kab operon (scheme 1.3),
23
 based on the 
first steps of the proposed aminoshikimate pathway, which produces 3-amino-5-
hydroxybenzoic acid (AHBA). Using electrospray mass spectrometry, Guo and Frost 
detected kanosamine and K6P as intermediates in this pathway, and it was suggested that 
they are the source of nitrogen for AHBA.
24
 The biosynthesis of kanosamine is believed 
to be performed by three proteins, RifL (oxydoreductase), RifK (aminotransferase), and 
RifM (UDPase).
24
 Overexpression of these three genes in E. coli was previously 
attempted and unsuccessful.
25
 A fourth enzyme, RifN, phosphorylates kanosamine to 
K6P (Scheme 1.4).
26
 A sequence alignment with the three first enzymes reveals a 
sequence identity of less than 16% with enzymes of the kab operon. This would suggest 
that the rif operon and the kab operons have different mechanisms for kanosamine 
biosynthesis. 
 
 
Scheme 1.4: The proposed first steps of the aminoshikimate pathway.  
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 Based on the high similarity between the ntd and kab operons, a biosynthetic 
pathway is proposed, whereby kanosamine is the end product (Scheme 1.5). It also takes 
into account previous data obtained on NtdA and NtdC. 
15-17
 This pathway would imply 
the presence of at least one more enzyme, found naturally in B. subtilis and E. coli but not 
in B. cereus, which would be responsible for the formation of the glycosidic bond. In this 
proposed scheme, NtdB would act as a phosphatase, removing the phosphate group of 
K6P.   
 
 
Scheme 1.5: The proposed biosynthetic pathway of kanosamine by the ntdABC operon from Bacillus 
sp. 
 
1.4 Hydrolysis of phosphate esters 
 
A phosphate ester contains at least one carbon attached to the phosphate oxygen 
(Figure 1.5).  Polyphosphate molecules contain more than one phosphate attached to one 
another, such as in ATP. 
 
 
Figure 1.5: A phosphate monoester. 
 R = any group bonded to the oxygen atom through a carbon atom. 
 
Hydrolysis of a phosphate ester is a thermodynamically favorable process which 
occurs via the attack from a water molecule on the phosphate. This process is slow due to 
the electrostatic repulsion between the negative charge of the oxygen surrounding the 
phosphate center and the oxygen of water.
27
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There are two hydrolysis mechanisms, dissociative and associative. The 
dissociative mechanism proceeds via a hydrated PO3
-
 anion. The associative mechanism 
requires a transition state which involves the formation of pentacoordinated phosphate.
28
  
A study using methyl phosphate under different conditions, such as different protonation 
state of the substrate and two forms of nucleophile, water and hydroxide anion, revealed 
the difficulty in distinguishing between both mechanisms, since they have similar 
activation barriers.
28,29
 
 
 Uncatalyzed, this hydrolysis reaction may take thousands of years.
30,31
 With the 
help of phosphatases, the hydrolysis of phosphate esters, occurs in seconds. Two 
mechanisms have been found to be used by enzymes, the direct transfer of the phosphoryl 
group to a metal coordinated water, and the formation of a phosphoenzyme 
intermediate.
32
 
 
1.4.1 Metallophosphatases 
 
Metallophosphatases use a one-step mechanism which involves one or two metal 
ions, such as magnesium, manganese, iron, or zinc, or a mixture of two, to help 
coordinate a hydroxide ion, which then acts as a nucleophile, attacking the phosphate 
group of the substrate (Figure 1.6).
33,34
 Many of these phosphatases are found in the 
serine/threonine superfamily, more specifically the major families, phosphoprotein 
phosphatase (PPP) and the metal dependent protein phosphatase (PPM), as well as purple 
acid phosphatase.
32,33,35
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Figure 1.6: Coordination of a hydroxide ion by two metals.  
The ion can act as a nucleophile, attacking the phosphate group. M1 and M2 represent two metal ions, such 
as zinc, iron, magnesium, or manganese, which are coordinated by residues in the enzyme.  
 
1.4.2 Phosphoenzyme intermediate 
 
The second mechanism involves a nucleophilic attack by an active site amino acid 
on the substrate leading to the formation of a phosphoenzyme intermediate, followed by a 
hydroxide nucleophilic attack on this intermediate, causing the release of the phosphate 
group from the enzyme (Figure 1.7). To coordinate the phosphate group, phosphatases 
use either amino acids within their active site or metal cofactors. 
 
 
Figure 1.7: Two steps mechanism for phosphatases.  
The attack of the nucleophile leads to the formation of a phosphoenzyme intermediate, which is attacked by 
a water molecule. The phosphate group is coordinated by either residues in the enzyme or metal cofactor. 
 
Different residues were found to perform the first nucleophilic attack, such as 
cysteine, serine, histidine, or aspartate (Table 1.1). The same variability in the identity of 
the general acid/base is found. It was proposed that some protein tyrosine phosphatases 
(PTPases) do not use a general acid because the pKa of the leaving group is low.
36, 37
 For 
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phosphonatases in the haloacid dehalogenase (HAD) superfamily, a Schiff base 
mechanism is used to catalyze the reaction.
38
  
 
Table 1.1: Comparison of different nucleophilic residues used by phosphatases. 
Nucleophilic 
residue 
Cysteine Serine Histidine Aspartate 
Major examples PTPases
39
 Alkaline 
phosphatases
40,41
 
Many acid phosphatases,
42
 
Glucose 6-phosphatase
43
 
FCP/SCP
35
 
HAD
44
 
Conserved active 
site  
CxxxxxR DSA/G RHGxRxP DxDxT/V 
General 
acid/base 
Aspartate or 
Glutamate
37
 
or None
36
 
Zn
2+
 and 
Mg
2+ 
 
Histidine 
 
Aspartate or 
Enamine 
intermediate
38
 
Coordination of 
phosphate 
Arginine Arginine Arginine Mg
2+
 
Abbreviation: SCP, small C-terminal domain phosphatase; HAD, haloacid dehalogenase; 
1.5 Assigning NtdB to a superfamily 
 
A protein BLAST search
45
 using the NtdB protein sequence as query, identifies 
this enzyme as belonging to the HAD superfamily. The HAD superfamily, characterized 
in 1994, was named after the haloacid dehalogenase and can be found in all organism 
domains.
46
 Contrary to what the name indicates, this superfamily is primarily composed 
of enzymes catalyzing the transfer or removal of a phosphate group on a wide range of 
phosphorylated substrates.
44
 
 
1.5.1 Structure of HAD phosphatases 
 
Members of the HAD superfamily contain two distinct domains; the core, where 
catalysis occurs, and the cap, which regulates access to the active site by different means, 
such as limiting the solvent access or providing substrate specificity.
44
 The cap domain 
can be further divided in three categories, C0, C1, and C2, based on its secondary 
structure. The crystal structure of NtdB from B. subtilis was solved in 2009
47
 (PDB 
3GYG, figure 1.8) and clearly shows the presence of these two distinct domains, 
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connected together via a hinge loop (P205-G208) and a partially disordered α-helix 
(N109-G118). The magnesium cofactor is bound in the core domain.  
 
Figure 1.8: Crystal structure of NtdB.  
The core domain is at the bottom and in magenta while the cap domain is at the top, in blue. Magnesium is 
indicated in green (PDB 3GYG). 
 
 
The common overall structural arrangement favors the following catalytic cycle 
for members of the HAD superfamily possessing a C1 cap domain (Figure 1.9). In the 
absence of substrate, the enzyme is in the open conformation, allowing the substrate to 
bind to the active site located in the core. The magnesium cofactor helps to orient the 
phosphate group of the substrate. The enzyme adopts a closed-conformation, preventing 
any solvent from reaching the active site. A nucleophilic attack by aspartate on the 
substrate occurs within the active site, creating an aspartate-bound intermediate. Then, 
the enzyme reverts back to its open conformation, protonating and liberating the 
dephosphorylated substrate, and allowing solvent to access the active site. The water 
molecule is deprotonated by the general base and acts as a nucleophile, attacking the 
aspartate-bound intermediate. The inorganic phosphate is released and the enzyme 
returns to its original state.
44
  
Cap domain 
Core domain 
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Figure 1.9: The catalytic cycle for members of the HAD superfamily possessing a C1 cap domain 
 
The important structural feature emerging from this catalytic cycle is the 
alternations between open and closed conformations. This allows the solvent to be 
included or excluded depending on the step of the reaction. It was proposed that a similar 
cycle occurs for enzymes containing a C2 caps.
44
 
 
1.5.2 Secondary structure of the core domain 
 
The core domain of members of the HAD superfamily is characterized by the 
presence of a Rossmann-like fold. Typically, Rossmann folds are present when an 
enzyme binds nucleotides, such as NAD(P) or FMN. In general, its structure consists of 
an alternation of α-helices and β-strands with a central β-sheet, containing five parallel β-
strands in a 54123 order (the numbering refers to the order of appearance in the amino 
acid sequence where S1 corresponds to Strand 1 and so on).
44,48
 Additionally, there is a 
conserved motif, GxGxxG, where the phosphate group of the nucleotide binds.
49,50
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As it can be seen in figure 1.10, NtdB contains an alternation of β/α motifs, the 
central β-sheet containing five strands in its core (Table 1.2). The absence of the 
conserved sequence of three glycine residues in its amino acids sequence indicates that 
NtdB does not contain a typical Rossmann fold and is less likely to bind a nucleotide. 
 
 
Figure 1.10: Identification of the structural characteristic of the core domain of NtdB, showing a 
Rossmann-like fold.  
S1 to S5 are identified in magenta, β-hairpin in pink, and magnesium in green (PDB 3GYG). 
 
Table 1.2: Amino acids corresponding to structural characteristics of the NtdB core domain  
Structural characteristic Amino acids 
Rossmann-like fold  
S1 Y20 – D25 
S2 L59 – T65 
S3 F87 – S90 
S4 A227 – G231 
S5 N245 – L248 
β-hairpin T94-Y98 and  G105-Q107 
 
Apart from the Rossmann-like fold, some additional structural elements in the 
core can be observed through members of different subcategories of the HAD 
superfamily. One of these elements can be observed in NtdB (Figure 1.10) and consists 
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of a β-hairpin, found after S3, and in the same plane as the Rossmann-like fold. This 
structural feature is found in sucrose-phosphate phosphatases (SPP),
51
 
phosphomannomutases,
52
 TPP,
53
 mannosyl-3-phosphoglycerate,
54
 and Cof-type 
phosphatases.
44
 
 
1.5.3 Conserved amino acid residues in the core domain 
 
Almost all members of the HAD superfamily contain four highly conserved 
motifs in the core domain and NtdB is no exception (Table 1.3).
44, 55
 
 
Table 1.3: NtdB contains the four conserved motifs found in the core domain of HAD superfamily 
members 
Conversed motif Amino acids in NtdB 
Motif 1 (DxD) D25 – X – D27  
Motif 2 (S/T) T65 
Motif 3 (K) K209 
Motif 4 (GDxxxD) G231 – D232 – X – X – X – D236 
 
 Motif 1, found at the end of S1, consists of the amino acid sequence DxD (where 
x represents any amino acid). The first aspartate acts as a nucleophile and forms the 
aspartate-bound intermediate. This intermediate was indirectly proven with different 
members of the HAD superfamily, using radioactive (
32
P) phosphate
56,57
 and mass 
spectrometry,
58, 59
 and directly observed in the crystal structure of β-phosphoglucomutase 
from Lactococcus lactis.
60
 This first aspartate also helps to coordinate the binding of 
magnesium.
61-63
 The second aspartate residue acts as a general acid-base for enzymes 
such as phosphatases, phosphotransferases,
53
 and phosphomutases.
44
 It can be replaced 
by alanine, for phosphonatases
61
 or threonine, in the case of P-type ATPases.
62
 
Regardless of the amino acid, its carbonyl group also helps to coordinate Mg
2+
.
61-63
  
 
 Motif 2 is highly conserved and contains either a serine or a threonine residue 
located at the end of S2. In the case of NtdB, this residue is a threonine. The side-chain  
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hydroxyl group is within hydrogen bonding distance of the phosphate oxygen, helping to 
orient it for nucleophilic attack by the aspartate.
64
 This serine or threonine residue is also 
present to stabilize the intermediate formed.
44, 60
  
 
 Motif 3 is composed of a conserved lysine residue, which is located at the middle 
or the end (in the case of NtdB) of the helix after S4. Its function is to stabilize the 
negative charges of the intermediate.
44, 64
 From crystal structures, such as sugar 
phosphatases
65
, and phosphoserine phosphatase
62
, it was observed that this residue forms 
a hydrogen bond with the first aspartate of Motif 1.
60, 61
 
 
 Motif 4 is a sequence containing two aspartates residues, either DD, GDxxxD, or 
GDxxxxD, located at the end of S4. These aspartates coordinate the Mg
2+
 in the active 
site,
38, 44, 61
and in some cases, via a water molecule.
53, 61
 For NtdB, the motif is GDxxxD. 
 
1.5.4 Secondary structure of the cap domain 
 
The cap domain of members of the HAD superfamily can be divided into three 
categories: C0, C1 and C2.
44
 NtdB possesses a C2 cap, inserted after S3 and 
characterized by a β-sheet, made up of at least three antiparallel β-strands. C2 caps are 
further subdivided into the HisB family, NagD family, and Cof hydrolase assemblage 
(which contains TPP and SPP, for example).
44
  
 
Due to its structure, NtdB is believed to belong to the Cof hydrolase assemblage, 
its cap resembling other phosphate phosphatases of this group. NtdB contains a β-sheet 
composed of three antiparallel β-strands, as well as two α-helices in an αβαββ pattern 
(see Table 1.4 and Figure 1.11). This is similar to the secondary structure of a 
phosphoglycolate phosphatase from Thermoplasma acidophilum (1L6R), which is from 
the Cof-hydrolase assemblage.
64
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Table 1.4: Amino acids corresponding to structural characteristics of the NtdB cap domain 
Cap motif Amino acids 
α1 S120 – N136 
β1 F154 – Q157 
α2 E161 – Y178 
β2 S197 – I203 
β3 V180 – R186 
 
 
 
Figure 1.11: Identification of the structural characteristic of the cap domain of NtdB.  
The β-strands are in orange and the α-helices in blue (PDB: 3GYG). 
  
1.5.5 Conserved amino acid residues in the cap domain 
  
The cap domain contains no specific amino acid motifs common to all members of 
the HAD superfamily. Instead, some commonalities can be found within specific sub-
groups. For members possessing a C2 cap, a common specificity loop has been 
proposed.
66
 This specificity loop serves to orient important residues, ensuring interaction 
with the leaving group of the substrate.
65
 In the case of a phosphoglycolate phosphatase, 
the specificity loop positions three polar residues for interaction with the glycolate 
portion of the substrate.
64, 65
 A more promiscuous enzyme, a sugar phosphatase from 
β1 
β2 β3 
α1 
α2 
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Bacteroides thetaiotaomicron, has two specificity loops containing one polar and two 
non-polar residues, respectively.
65
 
 
For NtdB, the crystal structure shows that this specificity loop contains 18 amino 
acids, R186 to I203. This is a relatively long loop compared to the other types of sugar 
phosphatases mentioned previously which contain only 9 or 10 residues.    
 
1.6 Proposed role of NtdB 
 
NtdB is proposed to act as a phosphatase and it possesses all the structural features 
of a phosphatase. In its core, not only does NtdB contain all four conserved motifs of 
members of the HAD superfamily, but it also contains features common to phosphatases 
such as the second aspartate of motif 1, and a β-hairpin, found after S3. NtdB possesses a 
C2 cap, common to members of the Cof family, and its αββαββ pattern is structurally 
closer to phosphatases than any other class of enzymes. Moreover, phosphatase activity 
has been observed with K6P.
67
 
 
1.7 Proposed catalytic mechanism of NtdB 
 
Based on the catalytic mechanism of members of the HAD superfamily and more 
specifically phosphatases, the following catalytic mechanism is proposed for NtdB 
(Scheme 1.6): 
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Scheme 1.6: Proposed catalytic mechanism of NtdB. 
 
First, Mg
2+
 binds to the side chain carboxyl group of D25, D232, and D236 of the 
enzyme, as well as the backbone carbonyl of D27 (not shown), with or without the help 
of water molecules. The enzyme is in the open conformation, allowing the 
phosphorylated substrate, K6P, to access the active site located in the core. T65 helps to 
orient the phosphate group in the right position for the next step. The enzyme adopts a 
closed-conformation, excluding bulk solvent from the active site. D25, which forms a 
hydrogen bond with K209 in the open conformation, is in the right position to perform a 
nucleophilic attack on the phosphate group, consequently forming a phospho-enzyme 
intermediate. 
 
The enzyme reverts back to its open conformation, liberating the 
dephosphorylated product, kanosamine, and allowing solvent to access the active site. 
The phospho-enzyme intermediate is stabilized by T65 and K209 until a water molecule, 
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deprotonated by D27, acts as a nucleophile on the phospho-enzyme intermediate. 
Inorganic phosphate is then liberated and the enzyme is returned to its original state.  
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2 RESEARCH PURPOSE 
 
2.1 Research Hypothesis 
 
The main hypothesis of this project was that NtdB belongs to the HAD superfamily 
and kanosamine-6-phosphate (K6P) is the native substrate. The active site residues would 
include D25, acting as a nucleophile, D27, performing the role of a general acid/base, 
T65 and K209, stabilizing the intermediate, and D232 and D236 coordinating the 
magnesium with D25. The cap domain would contain residues necessary for substrate 
binding. 
 
A second hypothesis was that, based on the similarity of the sequence, KabB 
performs the same role as NtdB. 
 
2.2 Research Objectives 
 
The long-term goal of this project is to understand how 3,3'-neotrehalosadiamine 
(NTD) is produced. This thesis focuses on the enzyme NtdB of the ntd operon. The first 
research objective was the purification of NtdB. Once pure, the phosphatase activity of 
NtdB could be investigated and its substrate specificity examined. A second objective of 
this thesis was to perform site-directed mutagenesis in order to investigate the proposed 
catalytic mechanism of NtdB as well as identify the essential amino acids in the cap 
domain of NtdB. An important aspect of this thesis was to obtain kinetic constants for the 
reactions catalyzed by NtdB and its mutants.  
 
As part of this research, KabB, an enzyme resembling NtdB was found. As part of 
this thesis, research on KabB was initiated. The research objectives related to KabB 
consisted of sub-cloning kabB in pet28b and expressing it in E. coli. The purification of 
KabB would allow to compared kinetics and substrate specificity between KabB and 
NtdB.  
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3 EXPERIMENTAL 
 
3.1 Materials and instrumentation 
 
3.1.1 Reagents and materials 
 
Chemicals and reagents were purchased from Alfa Aesar (Ward Hill, MA), Bio-
Rad (Mississauga, ON), EMD Millipore (Gibbstown, NJ), Sigma-Aldrich, Canada, Ltd. 
(Oakville, ON), TCI America (Portland, OR), or VWR (Mississauga, ON) and were of 
reagent grade or higher. DNA primers were synthesized by Alpha DNA (Montréal, QC). 
Restriction enzymes and their associated buffers were purchased from New England 
Biolabs (Pickering, ON). QIAprep
®
 Spin Miniprep kits were purchased from QIAGEN, 
Inc. (Toronto, ON), E.Z.N.A.
TM
 Plasmid Mini kits from Omega Bio-Tek Inc. (Norcross, 
GA), and EnzChek
®
 Phosphate Assay kits from Invitrogen Canada, Inc. (Burlington, 
ON).  For kinetics, NTD-6-phosphate, NTD-6'-phosphate, NTD-6,6'-bisphosphate and 
kanosamine-1-phosphate (K1P) were synthesized in Dr. Palmer’s lab by Dr. Shazia 
Anjum and Dr. Rajendra Jagdhane (Department of Chemistry, University of 
Saskatchewan, Saskatoon, SK, Canada). 
 
3.1.2 Plasmids, bacterial strains and growth conditions 
 
The pUC18-ntdABC plasmid encoding the ntdA, ntdB, and ntdC genes was 
provided by Dr. Kozo Ochi (Microbial Function Laboratory, National Food Research 
Institute, Tsukuba, Ibaraki, Japan). The pET-28b-ntdB plasmid was previously prepared 
by David Langill (Department of Chemistry, University of Saskatchewan, Saskatoon, SK, 
Canada).
15
 The pET-22b-kabABC and pET-15b-kabB plasmids were provided by Dr. 
Michael Thomas (Department of Bacteriology, University of Wisconsin-Madison, 
Madison, WI). Competent cells were generated from E. coli XL1-Blue and BL21-Gold
®
 
cell lines, purchased from Stratagene (la Jolla, CA). E. coli strains containing the desired 
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plasmid were routinely grown overnight at 37 °C in Luria-Bertani (LB) medium (with 
shaking at 250 rpm) or on LB-agar plates, either containing 50 µg/mL kanamycin or 
ampicillin. Plates were stored at 4 °C. 
 
3.1.3 Instrumentation 
 
Deionized water was purified using a Barnstead NANOpure
®
 DIamond
TM
 
(UV/UF) Ultrapure water system to 18.2 MΩ. Liquids and materials were sterilized using 
either an Accusterilizer AS12 (VWR) or Castle
® 
233LS Vacuum steam sterilizer 
(Getinge). A Virsonic 600 ultrasonic cell disrupter was used to lyse cells. The purity of 
proteins was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) on a Bio-Rad mini-PROTEAN
®
 3 electrophoresis system, and 
concentrations were determined using a NanoDrop
®
 ND-100 spectrophotometer. An 
Eppendorf Mastercycler
®
 Gradient thermal cycler was used for polymerase chain reaction 
(PCR). DNA separation and analysis was achieved using a Bio-Rad Mini-Sub
®
 Cell GT 
agarose gel electrophoresis system. A Beckman Coulter
®
 Avanti
®
 J-E centrifuge and 
Beckman Microfuge
®
 18 were used for DNA purification, cell harvesting, and protein 
sample preparation. A PiStar-180 spectrometer (Applied Photophysics) was used for 
circular dichroism (CD) experiments, where the temperature was controlled by an 
Isotemp 3016D (Fisher Scientific) circulating water bath. Spectrophotometric assays 
were accomplished using a Beckman DU-640 UV/Vis spectrophotometer, connected to a 
circulating water bath to control the temperature. DNA sequencing was performed by the 
DNA Technologies Unit of the National Research Council, Plant Biotechnology Institute 
(Saskatoon, SK, Canada). The Saskatchewan Structural Sciences Center (Saskatoon, SK, 
Canada) carried out mass spectrometric analysis of NtdB using an API Qstar
®
 XL 
MS/MS system with electrospray ionization source (ESI-Q-TOF) (Applied Biosystems, 
Toronto, ON). Nuclear magnetic resonance was performed with a Bruker Avance 500 
MHz UltraShield
TM
 NMR spectrometer. Spectra were calibrated at 4.79 ppm with 
residual water in D2O. 
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Protein sequences were found using GenBank
®68
 or Basic Local Alignment 
Search Tool (BLAST).
45
 Protein sequence alignments were generated with ClustalW
20
, 
using the Blosum scoring matrix
21
: opening gap penality = 10; extending gap penality = 
0.20; distance gap penality = 5. The sequence alignment images were created by ESPript 
V2.2
22
. Protein properties were calculated using the software Protein Calculator 3.3 
(http://www.scripps.edu/~cdputnam/protcalc.html) from The Scripps Research Institute 
(La Jolla, CA). The software Oligonucleotide Properties Calculator (OligoCalc)
69
 was 
used to generate primer sequences and NEBcutter v2.0
70
 to introduce restriction sites. 
Using chain A of NtdB (PDB 3GYG) as a template, homology modeling of KabB was 
performed using SWISS-MODEL.
71,72,73
  
 
3.2 Chemical synthesis 
 
3.2.1 Synthesis of K6P and Glucosamine-6-phosphate 
 
The synthesis of K6P and glucosamine-6-phosphate (GlcAm6P) followed the 
procedure of Guo and Frost.
24
 Kanosamine or glucosamine (110 mg, 0.61 mmol), ATP 
(500 mg, 1.00 mmol), citric acid (100 mg, 0.48 mmol), and MgCl2 (250 mg, 1.23 mmol) 
were dissolved in 35 mL distilled water, adjusted to pH 8.0 by the addition of aqueous 
NaOH, and degassed for 10 minutes with nitrogen.  To the solution, 6.3 mg (248 U) of 
hexokinase (from baker’s yeast) was added and stirred at room temperature.  The pH was 
monitored periodically and maintained between 7.5 and 8.0 by the addition of 1 M 
NaOH. After 24 hours of stirring, the hexosephosphate was purified from the reaction 
mixture by anion-exchange chromatography on AG
®
 1-X8 resin (acetate form, Bio-Rad) 
and eluted by sequentially adding 50 mL of increasing concentrations of acetic acid (0 N, 
0.5 N, 1.0 N, 1.5N, 2.0 N).  Ten mL fractions were collected and freeze-dried.  
 
Fractions containing the purified hexosephosphate were determined by 
1
H NMR 
and compared to literature values.
24,74
 K6P: 
1H NMR: δ ppm (500 MHz, D2O) 5.12 (d, 
1H), 4.57 (d, 1H), 3.95 (m, 2H), 3.84 (m, 1H), 3.78 (m, 2H), 3.63 (m, 2H), 3.44 (d, 1H), 
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3.25 (m, 2H), 3.01 (t, 1H). 
31P NMR: δ ppm (200 MHz, D2O) 1.80, 1.66. GlcAm6P: 
1
H 
NMR: δ ppm (500 MHz, D2O) 5.38 (d, 1H), 4.85 (d, 1H), 4.00 (m, 2H), 3.90 (m, 1H), 
3.84 (t, 1H), 3.59 (m, 2H), 3.51 (m, 2H), 3.25 (dd, 2H), 2.94 (dd, 1H).  
 
3.3 Biochemical procedures 
 
3.3.1 Buffers 
 
The buffers used in this thesis are listed alphabetically in Table 3.1. Competent 
cells were prepared with sterile Transformation buffer. For the protein purification 
protocol, filtered buffers B, W, and E were used, corresponding to the binding, wash and 
elution steps, respectively. Dialysis was performed either in dialysis buffer (for storage 
and kinetics) or CD buffer (CD experiments). All the kinetic assays were done in 
Universal buffer.    
 
Table 3.1: Content and pH of various buffers 
Buffers pH Content 
B 7.9 20 mM HEPES-HCl, 500 mM NaCl, 5mM imidazole 
CD 7.8 10 mM potassium phosphate, 15% glycerol 
Dialysis 7.5 20 mM HEPES-HCl, 500 mM NaCl 
E 7.9 20 mM HEPES-HCl, 500 mM NaCl, 55 mM imidazole 
SDS 8.7 25 mM Tris, 250 mM Glycine, 0.1% SDS 
TAE 8.0 40 mM Tris-acetate, 1mM EDTA 
Transformatio
n 
7.5 25 mM Tris-HCl, 57 mM CaCl2 
Universal Various 100 mM acetic acid, 50 mM Bis-Tris, 50 mM TEA 
W 7.9 20 mM HEPES-HCl, 500 mM NaCl, 30 mM imidazole 
Abbreviations: Bis-Tris, bis(2-hydroxyethyl)-amino-tris(hydroxymethyl)-methane; EDTA, 
ethylenediaminetetraacetic acid; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; SDS, 
Sodium dodecyl sulfate; TAE, tris-Acetate-EDTA; TEA, triethanolamine; 
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3.3.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
 
SDS-PAGE was performed using acrylamide-bisacrylamide gels and a Tris-glycine  
buffer (SDS buffer) system as described by Sambrook and Russel.
75
 The resolving gel 
and the stacking gel had acrylamide-bisacrylamide concentrations of 12% and 4.5% 
respectively. Gels were electrophoresed at 90 V for 15 min followed by 200 V for 30 min 
at room temperature.  
 
To visualize the proteins, gels were stained by soaking in Fairbanks A (0.05% w/v 
coomassie brilliant blue, 25% v/v isopropanol, 10% v/v glacial acetic acid), heating for 
30 seconds in a microwave (700 watts) followed by gentle rocking at room temperature 
for 5 min. Gels were then rinsed with distilled water. To destain the gels,  the same 
procedure was applied, using successively Fairbanks B (0.005% w/v coomassie brilliant 
blue, 10% v/v isopropanol, 10% v/v glacial acetic acid), Fairbanks C (0.002% w/v 
coomassie brilliant blue, 10% v/v glacial acetic acid), and Fairbanks D (10% v/v glacial 
acetic acid).  
 
3.3.3 Preparation of BL21-Gold® and XL1-Blue competent cells  
 
E. coli BL21-Gold
®
 competent cells, and E. coli XL1-Blue competent cell, were 
prepared as follows: 5 mL of LB broth containing 50 µg/mL of tetracycline was 
inoculated with frozen glycerol stock of the desired strain and incubated at 37 °C and 250 
rpm overnight. The overnight culture (1 mL) was used to inoculate 150 mL of LB broth 
with tetracycline (30 µg/mL) and incubated at 37 °C with shaking at 250 rpm until 
achieving an optical density at 600 nm of approximately 0.4. The cell culture was 
harvested by centrifugation at 1 500 x g for 20 minutes at 4 °C. The cell pellet was 
resuspended in 20 mL ice-cold transformation buffer and incubated on ice for 30 minutes. 
The resuspended cells were pelleted as before and resuspended in 5 mL ice-cold 
transformation buffer. The competent cells were diluted with sterile, ice-cold 80% 
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glycerol to a final concentration of 15% glycerol and aliquots of 100 µL were stored at -
80 °C until used. 
3.3.4 Transformation 
 
A 100 µL frozen aliquot of BL21-Gold
®
 or XL1-Blue competent cell was thawed 
on ice before adding 2 µL of the desired plasmid. The transformation mixture was 
incubated on ice for 30 minutes, followed by 42 °C for one minute, and placed back on 
ice for two minutes. The transformation mixture was used to inoculate 900 µL of pre-
warmed LB broth and incubated at 37 °C with shaking at 250 rpm for one hour. One 
hundred µL of the culture was spread onto a pre-warmed LB-agar plate containing 50 
µg/mL kanamycin. The plate was allowed to incubate overnight at 37 °C, yielding several 
colonies. 
 
3.3.5 Plasmid isolation 
 
E. coli XL-1 Blue cells containing the desired plasmid were grown overnight in 5 
mL LB broth containing 50 µg/mL kanamycin, at 37 °C with agitation at 250 rpm. The 
cell culture was harvested by centrifugation at 18 000 x g for 3 minutes at ambient 
temperature. Plasmid was isolated in distilled water using a QIAprep
®
 Spin Miniprep kit 
or E.Z.N.A.
TM
 Plasmid Mini kit, according to the manufacturer's protocol.  
 
3.3.6 Polymerase chain reaction 
 
Polymerase chain reaction (PCR) was performed using a KAPA HiFi
TM
 PCR kit. 
Each reaction contained 50 ng of desired plasmid, 0.3 mM deoxyribonucleotide 
triphosphate mix (equal amounts of each dATP, dCTP, dGTP, and dTTP), 0.8 µM of 
forward and 0.8 µM reverse primers of the desired mutation, 1X KAPA HiFi
TM
 buffer, 
and 1 U KAPA HiFi
TM
 DNA polymerase (25 µL final volume). A negative control 
without DNA polymerase was also performed. The PCR cycling protocols all started with 
 29 
 
an initial denaturation at 95 °C for 2 or 5 minutes which was followed by cycling three 
steps: denaturation, annealing and polymerization. The protocol ended with a final 
extension at 72 °C for 3 minutes.  
 
To remove the parental DNA, the amplification products were treated with DpnI 
and incubated at 37 °C for 1 hour. A positive control without DpnI was also performed. 
E. coli XL1-Blue competent cells and E. coli BL21-Gold
®
 competent cells were 
transformed with the resulting mixture using the transformation protocol previously 
described. Colonies from the plates were grown overnight in 5 mL LB broth containing 
50 µg/mL kanamycin, at 37 °C with agitation at 250 rpm. The plasmids were isolated as 
described in the previous subsection and the presence of the desired sequence in the 
plasmids was confirmed by nucleotide sequencing. 
 
3.4 Molecular biology 
 
3.4.1 Site-directed mutagenesis of the ntdB gene 
 
NtdB was previously sub-cloned into pET-28b.
15
 The plasmid encodes a 
hexahistidine tag at the N-terminus of the protein. Different mutations in the cap domain 
(R149K, H152F, C187A, D193N, D196N, D199N, D201N) and the core domain (D25N, 
D27A, D27N, T65A, T65S, K209E, K209R, D232A, D236A) of NtdB were introduced 
(Table 3.2). (Note: unless otherwise specified, mutants will be referred to by their amino 
acid substitution, and refer to NtdB.) Restriction sites were introduced in some mutants 
with the addition of a silent mutation. D27A and D27N contained a PvuI restriction site, 
T65A contained a SacI restriction site, and K209E and K209R contained an AccI 
restriction site. No convenient silent mutations leading to the addition of a useful 
restriction site could be created for the remaining mutations. D25N contained three silent 
mutations in order to increase the GC content of the primers. The pET-28b-ntdB plasmid 
(isolated as described above) was used as a template for the mutagenesis reaction and the 
mutagenic primers are listed in Table 3.3.  
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Table 3.4: PCR cycling protocol for the mutagenesis of ntdB 
Mutation Initial 
denaturation 
Denaturation Annealing Polymerization 
and extension 
Cycles 
D25N 95 °C  300 s 98 °C  20 s 56 °C to 64 °C  15 s 72 °C  180 s 30 
D27A 95 °C  120 s 98 °C  20 s 55 °C to 65 °C  30 s 72 °C  180 s 16 
D27N 95 °C  120 s 98 °C  20 s 55 °C to 65 °C  30 s 72 °C  180 s 16 
T65A 95 °C  120 s 98 °C  20 s 55 °C to 65 °C  30 s 72 °C  180 s 16 
T65S 95 °C  300 s 98 °C  30 s 55 °C to 65 °C  60 s 72 °C  180 s 16 
R149K 95 °C  300 s 98 °C  20 s 58 °C to 63 °C  15 s 72 °C  180 s 25 
H152F 95 °C  300 s 98 °C  20 s 60 °C to 65 °C  15 s 72 °C  180 s 30 
C187A 95 °C  300 s 98 °C  20 s 58 °C to 63 °C  15 s 72 °C  180 s 25 
D193N 95 °C  300 s 98 °C  20 s 60 °C to 65 °C  15 s 72 °C  180 s 30 
D196N 95 °C  300 s 98 °C  20 s 60 °C to 64 °C  60 s 72 °C  180 s 16 
D199N 95 °C  300 s 98 °C  20 s 60 °C to 65 °C  15 s 72 °C  180 s 30 
D201N 95 °C  300 s 98 °C  30 s 55 °C to 65 °C  60 s 72 °C  180 s 16 
K209E 95 °C  300 s 98 °C  30 s 55 °C to 65 °C  60 s 72 °C  180 s 16 
K209R 95 °C  300 s 98 °C  30 s 55 °C to 65 °C  60 s 72 °C  180 s 16 
D232A 95 °C  300 s 98 °C  20 s 56 °C to 64 °C  15 s 72 °C  180 s 30 
D236A 95 °C  300 s 98 °C  30 s 56 °C to 60 °C  60 s 72 °C  180 s 16 
 
 
The PCR protocol followed the methodology described before, using four 
different cycling protocols (Table 3.4).  
 
3.4.2 KabB 
 
3.4.2.1 Polymerase chain reaction amplification  
 
One colony of pET-22-kabABC was used to inoculate 5 mL LB broth containing 
50 µg/mL ampicillin which was grown overnight at 37 °C, with agitation at 250 rpm. The 
cell culture was pelleted by centrifugation at 18 000 x g for 3 minutes at room 
temperature, and the plasmid was isolated using an E.Z.N.A.
TM
 Plasmid Mini kit. 
Amplification of the kabB gene was performed using PCR, following the same procedure 
outlined previously (§3.3.6), using pET-22-kabABC. The initial denaturation was 
performed at 95 °C, for 300 seconds, followed by 28 cycles consisting of: denaturation 
(98 °C, 20 seconds), annealing (55-57 °C, 15 seconds), and extension (72 °C, 90 
seconds).   The kabB primers used for PCR amplification can be found in Table 3.5. The 
primers introduced two restriction sites: NdeI in the 5′ end and BamHI in the 3' end of the 
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gene. The PCR product was purified from the reaction mixture following the QIAquick
®
 
PCR purification kit protocol from Qiagen. 
 
 
Table 3.5: Primers for kabB PCR amplification 
 Primer Oligonucleotide sequence (5′ → 3′) Tm (°C) 
KabB Forward 
Reverse 
GGAGGGATTAAcatATGTCAATAAGTAATGAAG 
CATTATATGAggATCCCCTTTAATTAATAATGTG 
58.2 
57.3 
Unchanged nucleotides are upper case, while mismatched nucleotides are lower case, and restriction sites 
are underlined. 
 
3.4.2.2 Restriction digest of pET-28b and kabB 
 
One microgram of pET-28b plasmid or kabB PCR amplified fragments was 
incubated in NEBuffer #3 (5 µL) containing Bovine Serum Albumin (10 µg) and NdeI 
(30 U) for one hour, at 37 °C. BamHI (20 U) was added to the mixture, which was then 
incubated for an additional hour (final volume 50 µL). Restriction enzymes and 
fragments less than 100 bp were removed using a QIAquick
®
 PCR purification kit. 
 
3.4.2.3 Ligation of kabB into pET-28b 
 
The ligation reaction was prepared at a 3:1 insert-to-vector molar ratio. The 
ligation mixture contained 15 fmol of kabB PCR amplified fragments, 5 fmol pET-28b 
plasmid, and T4 DNA ligase (20 U) in 1X T4 DNA ligase buffer (final volume 10 µL). 
The ligation mixture was incubated overnight at 16 °C. The ligation mixtures were used 
to transform XL1-Blue competent cells as described above. Plasmids were isolated from 
the colonies of transformed cells using the methodology mentioned previously. To 
confirm successful ligation, a restriction digest using SapI was performed and the 
products were visualized on a 1% agarose gel containing GelRed
TM
 dye (Biotium Inc.) 
that had been developed in TAE buffer at 120 V. The presence of the intact kabB gene in 
plasmids containing a SapI restriction site was confirmed by nucleotide sequencing. 
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3.4.3 KabB mutant 
 
One mutation in the cap domain of KabB (N201D) was performed, which 
consisted of a single base pair change at position 601, from adenine to guanine. The pET-
28b-kabB plasmid (isolated as described above) was used as a template for the 
mutagenesis reaction and the mutagenic primers are listed in Table 3.6. 
 
Table 3.6: Mutagenesis primers of KabB N201D and their melting temperatures 
 Primer Oligonucleotide sequence (5' → 3') Tm (°C) 
N201D Forward 
Reverse 
GCTGGTGATCCAGAAgATTGCTATGATGTAG  
CTACATCATAGCAATcTTCTGGATCACCAGC 
61.7 
 
Unchanged nucleotides are upper case, while mismatched nucleotides are lower case, and restriction sites 
are underlined. 
 
 The PCR protocol followed the methodology described before. The initial 
denaturation was performed at 95 °C, for 300 seconds, followed by 16 cycles consisting 
of: denaturation (98 °C, 20 seconds), annealing (60-64 °C, 60 seconds), and extension (72 
°C, 180 seconds).  DNA sequencing confirmed the presence of the desired mutation.  
 
3.5 Protein expression and purification 
 
3.5.1 Growth and induction of the desired plasmid 
 
One colony of the desired plasmid was used to inoculate 5 mL LB broth, 
containing 50 µg/mL kanamycin, and incubated at 37 °C, with agitation at 250 rpm 
overnight. Of the overnight culture, 2 mL were used to inoculate 500 mL of LB broth 
containing kanamycin (50 µg/mL), which was then incubated at 37 °C, shaking at 250 
rpm, until an optical density at 600 nm of approximately 0.5 was obtained. The cells were 
induced with the addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and 
incubated for 2 hours at 37 °C, with agitation at 250 rpm. The cell culture was harvested 
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by centrifugation at 5 000 x g for 30 minutes at 4 °C and two aliquots of approximately 
0.4 g of wet cells were frozen at -20 °C until used. 
 
3.5.2 Purification of NtdB, KabB, and mutants  
 
One aliquot of frozen cells (§3.5.1) was resuspended in 5 mL buffer B and lysed by 
sonication at power 3, carrying out 36 cycles of 5 seconds pulse and 20 seconds rest. The 
cell lysate was centrifuged at 20 000 x g and 4 °C for 20 minutes. Since all the proteins 
contained a His-Tag, the supernatant was filtered using a 0.45 µM syringe filter and 
purified by a Ni
2+
-affinity chromatography with a 1 mL HiTrap
TM
 IMAC FF column (GE 
Healthcare), which was pre-treated with 100 mM NiSO4 and equilibrated with buffer B. 
The sample was loaded and the column was washed with buffer B (10 column volumes) 
and buffer W (10 column volumes). The protein was then eluted with buffer E (10 
column volumes). Column fractions were analyzed by SDS-PAGE, and those containing 
the desired enzyme were combined and dialyzed twice in a period of 24 hours against 1 L 
dialysis buffer. The protein was stored at -80 °C in 25% glycerol. 
 
3.6 Circular dichroism 
 
Pure wild type (WT) NtdB, KabB, and mutants were dialyzed against 1 L CD 
buffer, twice in a period of 24 hours.  Far-UV CD measurements were performed at a 
temperature of 4 °C. The CD instrument was calibrated with a solution of 4 mM (1S)-(+)-
10-camphorsulfonic acid at 290.5 nm. CD spectra were recorded from 190-260 nm in a 
0.5 mm cell, using a 6 nm bandwidth, and a scan speed of 5 nm min
-1
. Each spectrum was 
generated from the average of 4 scans. CD spectra were corrected with respect to the 
baseline, corresponding to the CD buffer, and subjected to curve-smoothing. The molar 
ellipticity ([θ]) was calculated from the ellipticity given by the instrument (θ), the 
molecular weight of the protein (MW), the protein concentration (C), the cell pathlength 
(l) and the number of amino acids in the protein (NA), according to equation 3.1
76
. CDNN 
deconvolution software
77
 version 2.1 was used to estimate secondary structure.  
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[θ] 
100 θ M 
C l NA
  (3.1) 
3.7 Kinetics 
 
Kanosamine-6-phosphate (K6P) stock solutions were prepared weekly and 
contained sodium acetate as an impurity (confirmed by HPLC).
17
   
 
3.7.1 para-Nitrophenylphosphate assay 
 
The assay mixture contained universal buffer and 20 mM para-
nitrophenylphosphate. After 10 minutes incubation at ambient temperature, 500 nM 
NtdB, KabB, or mutants were added to the solution for a final volume of 1 mL. The 
formation of para-nitrophenol was monitored by spectrophotometer at 410 nm, and its 
concentration calculated using Beer's law (3.2) The extinction coefficient of para-
nitrophenylphosphate is 18 400 M
-1
 cm
-1
.
78
 
 
3.7.2 Malachite green assay 
 
To prepare the Malachite Green solution, 250 mL of 4.2% (w/v) ammonium 
molybdate in 4 M HCl was added to 750 mL of 0.045% (w/v) Malachite Green for a final 
volume of 1 L.
79
 The solution was stirred for 30 minutes and filtered through a 0.22 μm 
filter and stored at 4 °C for up to six months. Tween 20 (0.1%, v/v) was added to aliquots 
of filtered Malachite Green solution before use. 
 
The assay mixture contained 25 nM NtdB, 10 mM MgCl2, and universal buffer. 
The reaction was initiated with the addition of various concentrations of K6P for a final 
reaction volume of 250 µL. The reaction was stopped at different times with the addition 
of 500 µL of malachite green solution, and incubated at room temperature for 45 minutes. 
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Each assay was performed in triplicate. The reaction mixture without enzyme was used as 
a blank. 
 
The formation of the phosphomolybdate-malachite green complex was monitored 
at 620 nm. Quantification of phosphate released from the reaction was accomplished 
using a standard curve generated using fixed concentrations of phosphate. 
 
3.7.3 EnzChek® Phosphate assay 
 
The kinetic assays followed the procedure of the EnzChek
®
 Phosphate Assay kit, 
with modifications in the content of the assay mixture. The assay mixture contained 
universal buffer, 10 mM MgCl2, 200 µM 2-Amino-6-mercapto-7-methylpurine 
ribonucleoside (MESG), one unit of purine-nucleoside phosphorylase (PNP), and various 
concentrations of substrate. The mixture was incubated at room temperature for 10 
minutes. The coupled reaction was initiated by the addition of 25 nM, 250 nM, or 500 
nM of enzyme (1 mL final volume). Each assay was duplicated.  
 
The formation of 2-Amino-6-mercapto-7-methylpurine (AMMP) was monitored 
at 360 nm, which corresponded to the formation of inorganic phosphate from the 
reaction. The increase in concentration of Pi (ΔC) was calculated the Beer’s law (3.2). 
 
    
  
  l
  (3.2) 
 
where ΔA represents the change in absorbance per second approximated from the slope 
of the initial segment of the reaction curve, ε is the extinction coefficient of AMMP (11 
000 M
-1
 cm
-1
)
80
, and l is the path length (1 cm).   
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3.7.4 Data analysis 
 
The kinetic data was fitted by non-linear regression to the Michaelis-Menten 
equation (3.3) using Sigma Plot v.11.0 software (Systat Software, Inc.), 
 
 o       
   
      
  (3.3) 
 
where V0 is the initial velocity, which is the change in concentration per second (ΔC), 
Vmax the maximum velocity, [S] the substrate concentration, and Km the Michaelis-
Menten constant for the substrate.   
 
The kcat value was calculated from Vmax and [E]0 according to the Equation 3.4 
 
 c t  
    
[ ] 
 (3.4) 
 
where [E] corresponds to the total concentration of NtdB, KabB, or mutants in the 
reaction.  
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4 RESULTS AND DISCUSSION 
 
4.1 Purification of NtdB 
 
Subcloning of ntdB has previously been described.
15
 The successful overexpression 
of ntdB in E. coli strain can be observed in Figure 4.1. For in vitro analysis of NtdB, the 
enzyme needed to be purified to homogeneity from the crude cellular extract. To avoid 
aggregation and obtain solubility, it was recommended to use a pH at least one or two 
units away from the isoelectric point of the protein. Using the software Protein Calculator 
3.3, the isoelectric point of NtdB was calculated to be 6.16. 
 
 
      
Figure 4.1: SDS-PAGE showing purification steps of WT NtdB. 
Lane 1: Ladder. Lane 2: Crude WT NtdB. Lane 3: Flow-through. Lane 4: Wash. Lane 5: Eluted WT NtdB. 
Lane 6: Ladder. Lane 7: Pure WT NtdB. 
 
NtdB contains a His-tag consisting of six histidine residues at the N-terminus. 
When the enzyme is passed through a chromatographic column containing Ni
2+
, the His-
tag chelates to the nickel, binding the enzyme to the column. All other non-tagged 
components flow through the column. We can observe in Figure 4.1 that the flow-
through contains very little, if any, NtdB. The wash step removed any loosely bound 
components and a small amount of NtdB can be perceived on the SDS-PAGE gel. When 
eluted, NtdB is the only component left.  
 
45.0 kDa 
36.0 kDa 
66.0 kDa 
29.0 kDa 
24.0 kDa 
1   2    3      4        5 
45.0 kDa 
36.0 kDa 
66.0 kDa 
29.0 kDa 
24.0 kDa 
6   7  
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The SDS-PAGE of pure WT NtdB was run next to a molecular weight ladder of 
known proteins (Figure 4.1, lane 6-7).  Visually, the mass of NtdB appears to be slightly 
higher than 36 kDa. The expected mass of NtdB, based on its amino acid sequence 
including its His-tag, was 34 732 Da. This small discrepancy in the molecular weight of 
NtdB could be due to the accuracy of the gel which is within the range of 5-10%.
81,82
 
There are several examples of proteins of similar molecular weight to NtdB that also 
show this unexpected behavior by SDS-PAGE. For example, pepsin (35 500 Da) has 
been shown to appear higher in molecular weight, while carboxypeptidase A (34 400 Da) 
appears lower.
82
  
 
4.2 Mass spectrometry of NtdB 
 
To confirm the actual weight of NtdB, mass spectrometry was used. Figure 4.2 
shows two molecular weights for NtdB. The smaller peak, observed at 34 733 ± 2 Da, 
corresponds to the expected theoretical weight of NtdB. The second peak was observed at 
34 602 ± 2 Da, a difference of 131 ± 3 Da, which is likely due to loss of the first 
methionine residue of the NtdB amino acid sequence.   
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Figure 4.2: Molecular mass of NtdB obtained by mass spectrometry. 
 
 In E. coli cytosolic proteins, it is not uncommon for this first methionine residue 
to be excised, and the identity of the second residue seems to affect the likelihood of this 
phenomena. When comparing over hundred E. coli protein sequences with different 
second residues, a strong positive correlation was observed between the presence of 
glycine, alanine, serine, cysteine, proline, or threonine residues, and the removal of 
methionine.
83
 Since an E. coli host was used to express His-tag NtdB and that the second 
residue is a glycine, it gives credence to the hypothesis that the mass of 34 602 Da 
observed in the mass spectrum comes from the excision of the first methionine residue. 
 
 Nevertheless, mass spectrometric analysis confirms that the molecular mass of 
NtdB is correct, despite the inaccuracy of the SDS-PAGE gel. 
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4.3 Kinetic assays of NtdB 
 
NtdB possesses all the physical characteristics of a HAD superfamily phosphatase 
(§1.5), such as the presence of a C2 cap domain, a core domain which contains a 
Rossmann-like fold, and several conserved amino acid residues, and motifs. Phosphatases 
remove a phosphate group from its substrate and the activity of such enzymes can be 
determined by different spectrophotometric methods, which measures consumption of 
substrate and/or production of product, or release of inorganic phosphate.  
 
4.3.1 para-Nitrophenylphosphate assay 
 
For more than 60 years, para-nitrophenylphosphate has been used as a substrate 
to easily assess the activity of bacterial phosphatases.
84
 When para-nitrophenylphosphate 
is dephosphorylated, the yellow product, para-nitrophenol, can be spectrophotometrically 
monitored between 390 nm and 410 nm (Scheme 4.1).   
 
 
Scheme 4.1: The hydrolysis of para-nitrophenylphosphate 
 
This non-specific substrate has been previously used on phosphatases structurally 
similar to NtdB: a phosphatase from Thermotoga maritima (1NF2);
85
 a phosphoglycolate 
phosphatase and trehalose-6-phosphate phosphatase from Thermoplasma acidophilum 
(1L6R and 1U02 respectively);
53, 64, 65
 and a sugar phosphatase from Bacteroides 
thetaiotaomicron (1YMQ).
65
 Table 4.1 summarizes the kinetic values reported in the 
literature using para-nitrophenylphosphate as a substrate.    
  
 42 
 
Table 4.1: Kinetic values of phosphatases structurally similar to NtdB using para-
nitrophenylphosphate as a substrate. 
PDB kcat (s
-1
) Km (mM) kcat/Km (M
-1
s
-1
) 
1NF2
85
 0.10 16 6.3 
1L6R
64
 0.58 3.1 190 
1U02
53
 0.80 17 47 
1YMQ
65
 0.083 0.77 110 
  
 
Based on the results reported with other phosphatases, 20 mM of para-
nitrophenylphosphate was used to test 500 nM NtdB. Activity was observed, confirming 
that NtdB act as a phosphatase (Figure 4.3.). The rate of the reaction was 0.0017 µM s
-1
 
and this extremely low activity would indicate that the specificity of NtdB is different 
from other phosphatases, even those with a similar structure. 
 
 
Figure 4.3: Hydrolysis of para-nitrophenylphosphate catalyzed by NtdB 
 
 It was concluded that the para-nitrophenylphosphate is a very poor substrate of 
NtdB, and therefore not a useful tool to determine the activity of the enzyme. This assay 
was not pursued. 
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4.3.2 Malachite green assay 
 
Since not all dephosphorylated substrates can be easily observed using a 
spectrophotometer, another type of assay can be used, monitoring the release of inorganic 
phosphate from the phosphatase reaction. In 1946, Soyenkoff published a method of 
phosphate determination based on the formation of an insoluble dye-phosphomolybdate 
complex, causing a color change of the dye.
86
 This method has been improved since, and 
presently, malachite green is the most commonly used dye, where the formation of the 
complex can be observed between 620 nm and 650 nm.
87
 The malachite green assay has 
been used to establish the kinetic parameters of many phosphatases throughout the 
years.
64, 79, 88
 
 
When tested with NtdB, the malachite green assay was successful, but limited 
(Figure 4.4). Using this assay, the results showed a very large variance. It is a 
discontinuous assay, whereby the reaction is stopped at precise time points (at least five) 
and the product, in this case phosphate, is measured. If this process is not automated, 
there is the possibility of a greater margin of error, which can be partially compensated 
for by repeating each experiment many times. These two factors make this assay a great 
consumer of substrates which were in limited quantity. This assay was abandoned in 
favor of the EnzChek
®
 Phosphate assay. 
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Figure 4.4: WT NtdB using malachite green assay.  
Michaelis-Menten curve of WT NtdB generated by Sigma Plot 11.0.Each point represents at least three 
measurements 
 
4.3.3 EnzChek® Phosphate assay 
 
Twenty years ago, Webb proposed a coupled assay, in which two reactions take 
place.
80
 The first reaction consists of the phosphatase under investigation 
dephosphorylating its substrate. The Pi released is used in the second reaction by purine-
nucleoside phosphorylase (PNP) in the presence of 2-amino-6-mercapto-7-methylpurine 
ribonucleoside (MESG), producing two compounds, ribose-1-phosphate (R1P) and 2-
amino-6-mercapto-7-methylpurine (AMMP). The latter product generates an absorbance 
peak at 360 nm which can be measured by UV spectrophotometry (Scheme 4.2). This is 
a continuous assay, since the release of Pi can be monitored as the reaction proceeds. 
 
Δ
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Scheme 4.2: Coupled reactions of the EnzChek
® 
phosphate assay.  
K6P is converted to kanosamine and Pi by the action of NtdB. The Pi is used to convert MESG to AMMP 
and R1P. The wavelength of AMMP was measured at 360 nm. 
  
The EnzChek
® 
phosphate assay is known to be effective in a narrow pH range and 
requires Mg
2+
 for activity. Therefore, the pH and metal ion-dependance of NtdB were not 
investigated.   
 
4.3.4 Kinetic values of WT NtdB 
 
The activity of an enzyme can be quantified using kinetics. The knowledge of the 
rate of an enzymatic reaction can help to predict a mechanism, identify substrates, and 
understand the function of an enzyme. The Michaelis-Menten equation (3.2) is a simple 
model establishing the relationship between the reaction rate and the concentration of 
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substrate for a fixed amount of enzyme. This model was used to establish the kinetics of 
NtdB and took into consideration its limitations: the amount of enzyme was much smaller 
than the amount of substrate used and only the initial rate of the reaction was measured.  
 
Using the Enzchek
® 
phosphate assay, NtdB was added to the reaction mixture 
containing various amounts of K6P. The formation of AMMP was monitored at 360 nm 
and the initial velocities were plotted against the substrate concentration. The initial 
velocities consisted of the straight-line portion of the graph, typically the first 60 seconds 
of the reaction.  Data were fitted to the Michaelis-Menten equation using non-linear 
regression (Figure 4.5).  
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Figure 4.5: Hydrolysis of K6P catalyzed by WT NtdB.  
Michaelis-Menten curve of WT NtdB generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements.  
   
The kinetic constants obtained give us information about the behavior of the 
enzyme. The kcat is a value indicating the turnover of substrate by an enzyme. The Km 
relates to the dissociation constant of the enzyme for its substrate. The ratio of these 
values, kcat/Km, is therefore a measure of the efficiency of the enzyme, mostly known as 
specificity constant.  
 
Δ
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If an enzymatic or chemical reaction is completely efficient, where every 
encounter leads to a reaction, the maximum value of the specificity constant will be in the 
order of 10
8
 to 10
9
 M
-1
s
-1
, where the rate limiting step is the diffusion rate and not the rate 
of the reaction.
89
 Most enzymes, in the presence of their native substrate, will present a 
specificity constant in the order of 10
5
 to 10
8
 M
-1
s
-1
.
90
 
 
The kinetic values were calculated using three methods: non-linear regression, 
Lineweaver-Burk plot, and Eadie-Hofstee diagram. These two last plots were very 
popular when computer analysis was not accessible to all; researchers needed to rely on 
graphical representation of the data.  
 
The Lineweaver-Burk is a double reciprocal plot based on the Michaelis-Menten 
equation yielding a straight line with the following equation (4.1):  
 
 
  
  
  
    
(
 
[ ]
)   
 
    
 (4.1) 
 
The y-intercept corresponds to the inverse of the Vmax, while the x-intercept 
represents the negative inverse of Km (Figure 4.6). This plot does not give equal weight 
to all data points when calculating the slope, such that data obtained at small 
concentrations of substrate have a significant impact on the value of the slope. But this 
graphical representation is a rapid diagnostic tool to evaluate the fitness of the data 
obtained.  
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Figure 4.6: Graphical representation of the Michaelis-Menten equation using a Lineweaver-Burk 
plot.  
The concentration of NtdB was 25 nM. 
 
The Eadie-Hofstee diagram is another graphical representation of the Michaelis-
Menten equation, where the reaction velocity is plotted against the ratio of velocity and 
substrate concentration (4.2).  
 
        (
  
[ ]
)        (4.2) 
 
The y-intercept represents Vmax, while the slope of this graph represents the 
negative Km (Figure 4.7). With this method, experimental errors are counted twice, since 
both axes are dependent on the initial velocities obtained and as such, neither are 
independent. But, it gives equal weight to all data points and is a rapid diagnostic tool. 
Table 4.2 summarize the different kinetic values obtained with all three methods. 
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Figure 4.7: Graphical representation of the Michaelis-Menten equation using an Eadie-Hofstee 
diagram.  
The concentration of NtdB was 25 nM. 
 
 Non-linear regression analysis resulted in the least amount of deviation between 
the calculated and the experimental data, and was therefore used to calculate kinetic 
values throughout this thesis. 
 
Table 4.2: Kinetic values of NtdB obtained using different methods of data analysis. 
Method used Vmax (µM s
-1
) Km (mM) kcat (s
-1
) kcat / Km (M
-1
s
-1
) 
Non-linear regression 0.80 ± 0.02 0.093 ± 0.007 32 ± 3 (3.4 ± 0.4) x 10
5
 
Lineweaver-Burk 0.88 ± 0.15 0.120 ± 0.020 35 ± 15 (2.9 ± 1.0) x 10
5
 
Eadie-Hofstee 0.82 ± 0.11 0.105 ± 0.016 33 ± 6 (3.1 ± 0.7) x 10
5
 
 
   
In the literature, many members of the HAD superfamily have been kinetically 
investigated, but the comparison of interest lies mainly with other phosphatases 
belonging to the Cof family which possess a similar cap as NtdB. A phosphoglycolate 
phosphatase with high substrate specificity and a sugar phosphatase with a broad range of 
substrates have been characterized previously (Table 4.3). The highly specific 
phosphoglycolate phosphatase has a specificity constant in the order of 10
5 
M
-1 
s
-1
, similar 
to that of NtdB, while the non-specific sugar phosphatase is several orders of magnitude 
lower. This would suggest that the native substrate of NtdB is K6P.  
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Table 4.3: Comparing NtdB specificity with other members of the HAD superfamily. 
PDB Name Substrate 
kcat 
(s
-1
) 
Km 
(mM) 
kcat / Km 
(M
-1
s
-1
) 
3GYG NtdB K6P 32 ± 3 0.093 ± 0.007 
(3.4 ± 0.4) 
x 10
5
 
1L6R 
Phosphoglycolate 
phosphatase
64
 
Phosphoglycolate 8.3 ± 1.5 0.037 ± 0.003 2.2 x 10
5
 
1YMQ 
Sugar phosphatase 
(BT4131)
65
 
2-deoxy-D-glucose 
6-phosphate 
26 ± 1 3.9 ± 0.4 6.7 x 10
3
 
  
4.4 Putative substrates of NtdB 
 
The activity of NtdB in the presence of K6P does not eliminate the possibility that 
it may be active with other substrates. Many enzymes are promiscuous or multispecific.
90
 
An array of substrates (Figure 4.8) was assayed with NtdB.  
 
 
 
Figure 4.8: Different substrates tested for NtdB activity.  
 
  
The structural similarity between trehalose-6-phosphate phosphatase (TPP) and 
NtdB (described in the introduction) highlighted the possibility that NtdB could be using 
a phosphorylated NTD as a substrate (Scheme 1.4b). To test whether this was the case, 
NTD-6-phosphate, NTD-6'-phosphate, and NTD-6,6'-bisphosphate were tested in the 
presence of NtdB. No phosphate release was detected for NTD-6,6'-bisphosphate. For 
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NTD-6-phosphate and NTD-6'-phosphate, very small but detectable activity was 
observed in the first minute of the reaction. There is doubt that this activity comes from 
the reaction of NtdB with the phosphorylated NTD because the activity disappears less 
than two minutes later, generating only a small amount of phosphate. The activity could 
be explained by some degradation of the phosphorylated NTD to K6P, or trace in the 
sample (contamination). NTD-6-phosphate and NTD-6'-phosphate are not commercially 
available and synthesis of more phosphorylated NTD would be required for further 
investigation, but the low level of phosphatase activity observed suggests that these are 
not good substrates of NtdB. 
 
A substrate closely related to K6P is D-glucosamine-6-phosphate (GlcAm6P, 
Figure 4.8). The structural difference between them lies in the location of the amino 
group, at C3 for K6P and at C2 for GlcAm6P. A small amount of activity was detected 
from NtdB in the presence of GlcAm6P, but it was too small to be kinetically 
investigated and as such was not considered a good substrate for NtdB.  
 
D-Glucose-6-phosphate (G6P) and kanosamine-1-phosphate (K1P) were also 
tested as substrates and neither triggered any activity from NtdB. This highlights the 
importance of the locations of the amino and phosphate group for substrate recognition 
and dephosphorylation by NtdB. In parallel with the observations made with GlcAm6P, 
NtdB seems to be highly specific for K6P. In the future, more substrates need to be 
assayed to validate this hypothesis. 
 
4.5 Mutagenesis of ntdB 
 
Once a substrate is found for an enzyme, such as K6P for NtdB, different 
experiments can be performed to try to explain the enzyme mechanism. One way to do so 
is by site-directed mutagenesis, in which targeted amino acid residues are selectively 
replaced with other residues. Effects on the kinetics can be observed and compared with 
the WT.  Based on comparisons with other phosphatases, study of the crystal structure, 
and the knowledge that K6P is the native substrate, 13 different amino acid residues were 
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selected for mutagenesis for a total of 16 mutants, 9 located in the core of the enzyme and 
7 in the cap (§4.8 and §4.9). 
 
To perform site-directed mutagenesis, nucleotides needed to be changed in the 
ntdB gene sequence. Primers containing the desired mutation were designed, using the 
software OligoCalc, such that the mutated nucleotide(s) were located at least 4 
nucleotides away from either end of the primer, the GC content was between 40% and 
60% whenever possible, the length was 20 to 40 base pairs, and the melting temperature 
was between 55 °C and 65 °C (Table 3.3). 
 
Site-directed mutagenesis followed the KAPA HiFi
TM
 PCR kit protocol, using 
different annealing temperatures for each mutant. Table 4.4 summarizes the successful 
annealing temperature for each mutant, which was found by creating a temperature 
gradient across the heating block during the annealing step of PCR. Amplification of the 
desired mutation was confirmed by agarose gel electrophoresis.  
 
Table 4.4: Annealing temperatures for mutants of NtdB 
Mutation Tm (°C) Annealing (°C) 
D25N 60.8 59 
D27A 64.5 63 - 65 
D27N 62.2 59.5 - 60.5 
T65A 64.3 60 - 63 
T65S 64.4 62 - 64 
R149K 60.8 59 
H152F 63.5 61 - 63 
C187A 62.0 60 - 62 
D193N 63.0 62 - 63 
D196N 63.0 61 - 63 
D199N 63.0 63 
D201N 64.5 65 
K209E 64.4 64 
K209R 64.4 63 - 64 
D232A 64.4 62 - 63 
D236A 60.3 58 
 
Plasmids containing the desired mutation were transformed into E. coli competent 
cells and after culturing onto agar plates, several colonies were observed, indicating 
 53 
 
successful mutagenesis. The presence of the desired mutation in the plasmids was further 
confirmed by nucleotide sequencing. 
 
4.6 Purification of mutants NtdB 
 
The purification process used for all mutants of NtdB was the same as that used for 
the WT (§4.1). Figures 4.9 and Figure 4.10 show the purity of mutants in the core and 
cap domains, respectively.  
 
 
 
Figure 4.9: SDS-PAGE of pure WT NtdB and mutants in the core domain. 
Lane 1: Ladder. Lane 2: WT NtdB. Lane 3: D25N. Lane 4: D27A. Lane 5: D27N. Lane 6: T65A. Lane 7: 
T65S. Lane 8: K209E. Lane 9: K209R. Lane 10: D232A. Lane 11: D236A. 
 
 
Figure 4.10: SDS-PAGE of pure WT NtdB and mutants in the cap domain.  
Lane 1: Ladder. Lane 2: WT NtdB. Lane 3: R149K. Lane 4: H152F. Lane 5: C187A. Lane 6: D193N. Lane 
7: D196N. Lane 8: D199N. Lane 9: D201N. 
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As was observed with the WT NtdB, the molecular weight of the mutants appeared 
higher than expected by SDS-PAGE, but still within error.
81, 82
  
 
4.7 NtdB mutants of the core domain 
 
Residues in the core domain of NtdB (D25, D27, T65, K209, D232, and D236) are 
believed to play a role in the proposed catalytic pathway of NtdB (Scheme 1.6), and 
belong to four motifs generally found in phosphatases.
91
 Since almost all members of the 
HAD superfamily contain the same four conserved motifs in their core, the roles of these 
amino acid are believed to be the same in all members of the HAD superfamily. It was 
hypothesized that mutations performed in the core of NtdB would have similar effects to 
those performed in the core of other members of the HAD superfamily. 
 
4.7.1 Motif 1 
 
The first motif contains two important aspartate residues believed to be essential 
for activity; D25, a proposed nucleophile and D27, a proposed general acid/base.  
 
The isosteric mutation of D25 to an asparagine residue was predicted to prevent 
activity of the enzyme. The neutral amid is much less nucleophilic than the negatively 
charged carboxylate, and this mutation would prevent the formation of the phospho-
enzyme intermediate. D25N presented no activity in the presence of K6P, confirming the 
importance of this residue in the active site of the enzyme and giving credence to its role 
as a nucleophile (Table 4.5).  
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Table 4.5: Kinetic parameters of NtdB mutants of the core domain. 
Motif Mut tion    (µM)  c t
 
(s-1)  c t /    (M
-1s-1) %  ctivity 
- WT   93 ± 7 32 ± 3 (3.4 ± 0.4) x 10
5
 100 
1 D25N No activity 
1 D27  No activity 
1 D27N No activity 
2 T65  < 1% activity 
2 T65  70 ± 6 22 ± 2 (3.1 ± 0.4) x 10
5
 69 ± 6 
3 K209E No activity 
3 K209R No activity 
4 D232  No activity 
4 D236  No activity 
 
 
D27 is believed to act as a general acid/base. This second aspartate residue was 
previously observed in the crystal structure of a phosphoserine phosphatase to be in a 
protonated state, forming two hydrogen bonds, one as acceptor with a neighboring 
threonine residue and one as donor to the phosphate.
62
 D27A was predicted to be 
prevented such a role and the loss of activity of this mutant in the presence of K6P 
confirmed this prediction. The isosteric mutation, D27N, allows the formation of 
hydrogen bonds but prevents any role as a general acid/base. This mutant could have 
retained some activity through hydrogen bonding or proton-relay. But, the lack of activity 
observed for this mutant in the presence of K6P supports the idea that D27 is acting as a 
general acid/base (Table 4.5).  
 
The results obtained for both aspartate residues in the first motif is in accordance 
with what has been observed in many other phosphatases. Site-directed mutagenesis 
performed on similar residues in other members of the HAD superfamily have yielded 
the same lack of activity (Table 4.6). Based on these results and the sequence alignment 
of NtdB with other members of the HAD superfamily, it was concluded that D25 and 
D27 very likely have the same roles as in other phosphatases, a nucleophile and a general 
acid/base, respectively. 
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Table 4.6: Comparing the percent activity of NtdB mutants in the core domain with other members 
of the HAD superfamily. 
Motif NtdB %
*
 PSP
58
 % PChP
92
 % MDP-1
93
 % sEHP
59
 % HAD
94
 % 
1 D25N 0 D20N 0   D10N 0 D9N 0 D10N <1 
   D20E 0 D31E 0 D10E 0 D9A 0 D10A 0 
 D27A 0 D22E 0 D33E 0 D12N 8 D11A 0   
 D27N 0 D22N 0         
2 T65A < 1 S109A 6 S166T 20 S68A 0.1 T123A 7 S118A 23 
 T65S 69 S109T 115     T123N 3   
3 K209R 0 K158R 1 K242R 57 K99R 1.4 K160R 0 K151R 0.02 
4 D232A 0 D179N 0.6   D122N 0.1 D185A 0   
   D179E 78 D262E 7       
 D236A 0 D183N < 0.4     N189A 0 D180N 0 
   D183E 63 D267E 2 N126D 52 N189D 0 D180E <1 
Abbreviations: PSP, phosphoserine phosphatase; PChP, phosphorylcholine phosphatase; MDP-1, 
Magnesium-dependant acid phosphatase; sEHP, soluble epoxide hydrolase phosphatase; HAD, haloacid 
dehalogenase. 
*
 % = % activity relative to WT enzyme. 
 
4.7.2 Motif 2 
 
In NtdB, the second motif contains a threonine and its hydroxyl group was 
proposed to perform two roles: help orient the phosphate for the nucleophilic attack and 
stabilize the intermediate. This residue was mutated to an alanine, as well as a serine, to 
evaluate its importance.  
 
T65 was mutated to alanine and was predicted to show no activity in the presence 
of K6P. This was the case and the lack of activity from the mutant is an indicator of the 
importance of the amino acid replaced.  The T65A mutant showed less than 1% activity 
in the presence of K6P, underlining the importance of this residue for the catalytic 
activity of NtdB. This result is in accordance with similar mutations performed in other 
phosphatases, where, in most cases, removing the hydroxyl residue causes a considerable 
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reduction in the activity of the enzyme since it is preventing the formation of hydrogen 
bonds (Table 4.6).  
 
The second mutation performed was T65S. Both serine and threonine residues 
contain a β-hydroxyl group to help stabilize the intermediate through hydrogen bonding 
but threonine also contains a methyl group, making this amino acid bulkier. Kinetic 
assays revealed that this mutant had reduced activity, but similar specificity (Figure 4.11 
and Table 4.5).  The difference in size between both residues may explain why threonine 
is a better amino acid at this position; the bulkiness of threonine helps achieve a proper 
orientation of the phosphate group in the active site. But, the behavior of this amino acid 
in motif 2 varies between the members of the HAD superfamily. The mutation of this 
amino acid residue had caused a considerable decrease in activity in the case of 
phosphorylcholine phosphatase
92
 and no change for phosphoserine phosphatase.
58
 In both 
of these enzymes, a threonine was changed to a serine, opposite of NtdB (Table 4.6).     
 
[K6P] M
0 100 200 300 400 500
[P
i]
 
M
 s
-1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
 
Figure 4.11: Hydrolysis of K6P catalyzed by T65S.  
Michaelis-Menten curve of T65S generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. Each 
point represents at least two measurements.  
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4.7.3 Motif 3 
 
The third motif contains a conserved lysine residue which is believed to stabilize 
the intermediate and has been shown to form a hydrogen bond with the nucleophile in 
related phosphatases. This lysine residue was mutated to glutamate and arginine. As 
expected, K209E showed no activity in the presence of the substrate (Table 4.5). The 
negative charge introduced could have prevented the formation of a hydrogen bond with 
D25, and created repulsion with the substrate and/or intermediate, preventing any 
stabilization.
44, 64
  
 
Since the mutant K209R conserved the positive charge and did not drastically 
modify the size of the residue, some activity should have been expected. However, no 
activity was observed in the presence of K6P for this mutant (Table 4.5). The effect of 
this mutation varies among phosphatase. In the case of phosphorylcholine phosphatase, 
the activity is only reduced approximately by half, still allowing the enzyme to function. 
Considerably reduced activity has been observed in others (Table 4.6). It is noteworthy 
that this lysine residue was reported to be poorly conserved in members of the HAD 
superfamily, compared to the other three motifs.
44
  
 
From these results it is apparent that K209 is catalytically important. In the future, 
either a crystal structure of K209R or modeling of K209R in the closed-conformation of 
NtdB could help identify the impact of the mutation on the hydrogen bonds with the 
nucleophile and the intermediate.    
 
4.7.4 Motif 4 
 
Both aspartate residues of motif 4 are believed to help with coordination of the 
magnesium ion, positioning the metal, and increasing the electrophilicity of the 
phosphate group, favoring nucleophilic attack.
44, 62
 The first aspartate would interact 
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directly with the magnesium ion while the second aspartate hydrogen bonds with a water 
molecule, which in turn coordinates with the magnesium ion.
53, 60, 61
  
 
Two amino acid residues, D232 and D236, were mutated to alanine in the fourth 
motif. In both cases, the mutation caused a loss of activity of NtdB in the presence of 
K6P (Table 4.5), as was expected based on mutations reported for other phosphatases, in 
which even the mutation to asparagine caused a considerable reduction in activity (Table 
4.6). 
 
 For NtdB, analysis of the different chains of the deposited crystal structure
47
 
reveals two different positions for the magnesium ion, the main difference being the 
coordination of either D236 or a water molecule (figure 4.12). In chains A, B, and D, 
D236 forms a hydrogen bond with a water molecule which coordinates the magnesium 
ion. In chain C, D236 coordinates directly to the magnesium, which is buried in the active 
site, and the water molecule seems to be in the position which would be occupied by the 
phosphate group of bound substrate.   
 
 
 
Figure 4.12: Comparing the magnesium ionic bonds of chains B and C of NtdB.  
Green sphere represents magnesium and blue sphere represents a water molecule (PDB 3GYG). 
 
A difference in the position of the magnesium ion was also observed in the crystal 
structure of a cyanobacterial sucrose phosphate phosphatase. The metal is coordinated 
through the water molecule in the open conformation. In the empty closed-conformation, 
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the metal is coordinated with the aspartate residue. When the crystals are soaked with the 
substrate sucrose 6-phosphate, both magnesium positions appear (Figure 4.13).
51
  
 
 
Figure 4.13: Two different positions for the magnesium ion in the closed-conformation of a sucrose 
phosphate phosphatase.  
PDB 1TJ5 
 
The following movement of magnesium ion is proposed for NtdB. In the open 
conformation of the enzyme, the magnesium favors the interaction with the water 
molecule. The phosphorylated substrate binds to the enzyme which then adopts a closed-
conformation, moving the magnesium ion deep in the active site. The nucleophilic attack 
occurs and the enzyme re-adopt the open conformation, releasing the leaving group and 
giving solvent access to the active site. The magnesium moves back to its original 
position, where the hydroxide ion performs a nucleophilic attack on the phosphoenzyme 
intermediate and inorganic phosphate is released. This proposition is supported by the 
observations made on the crystal structures of sucrose-phosphatase in different 
conformations and with different substrates (PDB 1S20, 1TJ5, 2D2V, 2B1Q, and 1U2S). 
 
The mutations performed on motif 1, 2 and 3 have put forth the importance of the 
alignment of the phosphate and the nucleophile for the enzyme to perform successfully. 
Similarily, the alignment of the magnesium, which coordinates the phosphate group, 
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would seem to be as important. Crystal structures of NtdB in the closed-conformation, 
with bound substrates, may help elucidate the movement of the magnesium ion.  
 
4.8 NtdB mutants of the cap domain 
 
As mentioned in the introduction, the cap is responsible for selectivity of each 
enzyme and differs among phosphatases. As more crystal structures of members of the 
HAD superfamily are solved, some commonalities among certain subcategories are 
starting to emerge. For example, phosphatases with a C2-type cap seem to possess a 
specificity loop, which orients some important residues of the cap.
64, 65
 The specificity 
loop presents in NtdB comprises residues R186 to I203, and is longer than other sugar 
phosphatases. 
 
A common methodology to initially identify important residues consists of 
modeling the desired substrate in the crystal structure of the enzyme, sometimes 
replacing a substrate already found in the active site. This method did not apply in this 
case since no crystal structure of NtdB in its closed-conformation exists at this time, and 
that modeling with the open conformation of NtdB using the software COOT
95
 did not 
give any functional results.  
 
Therefore, choosing amino acids in the cap of NtdB for mutagenesis was based on 
the observation that the location of the amino and phosphate groups of the substrate seem 
to be of primary importance for binding (§ 3.5). Focusing on the region of the specificity 
loop of NtdB, four aspartate residues were found in the cap domain: D193, D196, D199, 
and D201 (Figure 4.14). All four aspartic acids were mutated to asparagine, which 
removed the charge of these residues, but kept the size relatively constant. In the 
specificity loop, C187 was also identified near these aspartic residues and investigation of 
this amino acid through site-directed mutagenesis to alanine was performed. In the 
proposed substrate binding site formed by these four aspartate residues and the cysteine, 
the presence of two amino acids from a neighboring loop, R149 and H152, was observed, 
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and they were kinetically investigated. The pocket formed by these amino acid residues is 
the proposed substrate binding site. 
 
 
 
Figure 4.14: The amino acids of the cap domain surrounding the proposed substrate binding site. 
 
4.8.1 D193N 
 
D193 was initially believed to recognize the amino group of the substrate. This 
residue is located near the middle of the unusual long specificity loop. In the crystal 
structure of NtdB, this amino acid points in the direction of the active site. In the presence 
of K6P or GlcAm6P, D193N showed detectable but very small activity, and no activity 
with G6P (Table 4.7).  
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Table 4.7: Other substrates tested against NtdB and cap domain mutants. 
 (*** activity detected; * detectable but not quantifiable; - no activity). 
 
 
 
 
 
 
 
 
 
 
The drastic negative effect of this mutation on the activity of NtdB with K6P 
would indicate the importance of this amino acid (Table 4.8). But, since there was no 
activity with G6P, in which the only difference is the presence of a hydroxyl group 
instead of an amino group, this residue may play a role other than substrate recognition. 
Sometimes, the cap also contains residues that play a role either in substrate turnover or 
as a structural component.
44
 Due to its location, it is suggested that D193N plays a 
structural role in keeping the enzyme in the closed-conformation. This hypothesis would 
need to be further explored crystal structures of NtdB in its closed-conformation.    
 
Table 4.8: Kinetic parameters of NtdB mutants of the cap domain. 
Mutation Km (µM) kcat
 
(s
-1
) kcat / Km (M
-1
s
-1
) % activity 
WT   93 ± 7 32 ± 3 (3.4 ± 0.4) x 10
5
 100 
R149K 92 ± 9 38 ± 4 (4.1 ± 0.6) x 10
5
 120 ± 12 
H152F 110 ± 10 44 ± 4 (4.0 ± 0.5) x 10
5
 140 ± 13 
C187A 333 ± 46 0.58 ±0.05 (1.7 ± 0.3) x 10
3
 1.8 ± 0.2 
D193N Less than 1% activity 
D196N 134 ± 13 26 ± 3 (2.0 ± 0.3) x 10
5
 81 ± 9 
D199N No activity 
D201N 96 ± 9 1.6 ± 0.2 (1.7 ± 0.3) x 10
4
 5.0 ± 0.6 
 
 
 
Mutant K6P G6P GlcAm6P 
WT NtdB *** - * 
R149K *** - * 
H152F *** - * 
C187A *** - * 
D193N * - * 
D196N *** - * 
D199N - * * 
D201N *** * - 
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4.8.2 D196N 
 
D196 is located before the last anti-parallel β-strand of the cap and points out of 
the active site. Because of its position, the effect of mutating this aspartic acid was 
expected to be low. As seen in Table 4.8 and Figure 4.15, the activity was reduced to 
80% and its specificity reduced by less than half. It also has the same behavior as the WT 
NtdB in the presence of other substrates, such that there is no activity with G6P and some 
detectable, but very small, activity with GlcAm6P (Table 4.7). This would indicate that 
this residue is not a major player in the activity of the enzyme, or that its role is to form 
hydrogen bonds with one or more hydroxyl groups of K6P, hydrogen bonds that would 
still be present when mutated to asparagine.    
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Figure 4.15: Hydrolysis of K6P catalyzed by D196N.  
Michaelis-Menten curve of D196N generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements..  
 
 The crystal structure of a sucrose phosphate phosphatase with secondary structure 
similar to NtdB was solved in both the open and closed-conformation, allowing a 
movement of the cap to be observed (Figure 4.16).
51
 Because the specificity loop of 
NtdB is seven amino acids longer than the specificity loop of this sucrose phosphate 
phosphatase, movement of the cap may cause a change in orientation of D196, allowing 
Δ
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for contact with K6P. This hypothesis could be confirmed with a crystal structure of the 
closed-conformation of NtdB. 
 
 
Figure 4.16: Movement of the cap between the open conformation and the closed-conformation of a 
sucrose phosphate phosphatase.  
The arrow indicates the specificity loop in the closed-conformation. Open: Cyan, PDB 1S20; Close: 
Salmon, PDB 1TJ5. 
  
4.8.3 D199N and D201N 
 
D199 was proposed to play a central role in the binding of the substrate in the cap 
domain. The negatively charged carboxylate was presumed a key feature in the 
recognition of the amino group. The mutation to asparagine removed this charge, while 
keeping its potential for hydrogen bonds. In the presence of K6P, D199N showed no 
activity (Table 4.8), while in the presence of G6P, there was a small amount of activity 
that was detected (Table 4.7). This change in activity with both substrates supports the 
proposition that this amino acid is the main residue responsible for the recognition of the 
Active 
site 
 66 
 
amino group of K6P by NtdB. This would also be consistent with the proposed substrate 
binding site.  Further investigations of this amino acid residue are proposed, such as 
mutation to alanine to increase the substrate binding pocket size and remove any 
hydrogen bonding capability.  
 
D201 is proposed to have a similar role to D199. When mutated to asparagine, 
some changes in the substrate specificity of NtdB occur. With K6P, reduction of activity 
to 5% was observed (Figure 4.17). Additionally, no more activity was observed with 
GlcAm6P, while some activity was now seen with G6P (Table 4.7).  
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Figure 4.17: Hydrolysis of K6P catalyzed by D201N.  
Michaelis-Menten curve of D201N generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements.  
 
This change in substrate specificity not only indicates that this amino acid is an 
integral part of the substrate binding site, but also helps in proposing an orientation for 
K6P in the binding site. Figure 4.18a illustrates the binding interactions of the amino 
group of K6P to residues D199 and D201. GlcAm6P is characterized by an amino group 
at C2 instead of C3, and D201 may be the only residue holding this amino group in place 
(Figure 4.18b). Mutation to D201N would prevent the stabilization of the amino group 
and the enzyme would not recognize this substrate anymore.   
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Figure 4.18: Proposed orientation of the substrate with respect to D199 and D201.  
(A) K6P; (B) GlcAm6P 
 
  It is proposed that D199 and D201 represent the main amino acid residues 
responsible for the binding of the substrate. Both are on a β-strand and their relative 
orientation is not expected to change much upon movement of the cap domain. Their 
negative charge attracts the amino group of K6P and orients the substrate in the right 
position, allowing the enzyme to adopt the closed-conformation, and the nucleophile to 
attack the phosphate group. This combined negative charge repels the hydroxyl group of 
G6P and removal of either negative charge allows for small but detectable activity to 
occur with G6P. Again, a crystal structure of NtdB in its closed-conformation would help 
to confirm this hypothesis.  
  
(A) (B) 
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4.8.4 C187A 
 
Due to its location (Figure 4.19), it is proposed that the role of C187 is to orient 
D193 and D199. The mutant C187A would not be able to form the hydrogen bonds 
necessary to orient the aspartate residues properly.  
 
Figure 4.19: Hydrogen bond distance of C187 to D193 and D199 in the open conformation of NtdB. 
 
The mutation C187A reduced the value of kcat with K6P to 2%, while the Km is 
more than three times higher than with the WT (Figure 4.20 and Table 4.8). This would 
indicate that binding of the substrate is impaired, which could hinder and slow down the 
reaction..   
   
D193 
D199 
C187 
Specificity 
loop 
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Figure 4.20: Hydrolysis of K6P catalyzed by C187A.  
Michaelis-Menten curve of C187A generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements. 
 
Since D199 is likely responsible for binding the amino group and orienting the 
substrate, the lack of hydrogen bonds to D199 would make it more difficult for the 
substrate to bind, explaining the increase in Km.  C187 is also near D193, and the 
movement of the cap when the enzyme is adopting its closed-conformation may cause 
hydrogen bonds to form between both residues, helping to orient D193. If, as proposed, 
D193 is responsible for the proper structure of the closed-conformation, the lack of 
hydrogen bonding by C187A would impair orientation of D193, and prevent the reaction 
from proceeding, causing the drastic reduction observed in kcat.  
 
Therefore, it is proposed that C187 would play more of a structural role in the 
substrate binding site by helping to orient these two important aspartate residues. 
 
4.8.5 R149K and H152F 
 
 In the open conformation of NtdB, two other residues from a neighboring loop, 
R149 and H152, are observed in the region of the substrate binding site. It is proposed 
that in the open conformation, these two amino acid residues are positively charged and 
Δ
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help stabilize the negative charges of D193, D199, and D201 (Figure 4.21). In the 
closed-conformation, the neighboring loop to which they belong would be moved away 
from the substrate binding site.  
 
 
Figure 4.21: The hydrogen bond distance from R149 and H152 to aspartate residues in the open 
conformation for NtdB. 
 
R149K, which has a reduced side-chain length while conserving its positive charge, 
caused no change in activity, the values within error of the WT NtdB (Figure 4.22 and 
Table 4.8).  The positive charge may be the important feature of residues at this position 
but further mutations would be required to verify the importance of this residue in the 
substrate binding site.  
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Figure 4.22: Hydrolysis of K6P catalyzed by R149K.  
Michaelis-Menten curve of R149K generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements. 
 
 
Histidine residues have a pKa of 6 and are not expected to be positively charged at 
neutral pH. But, enzymes create microenvironments which may locally affect the pH and 
as such H152 may be positively charged. H152F removed this positive charge and any 
potential hydrogen bonding, while keeping the aromatic properties.
96
 An increase of 
activity up to 140% was observed (Figure 4.23 and Table 4.8) and may be due to a better 
access of the substrate to the aspartate residue in the binding site. These results would 
suggest that H152 is positively charged and that the charge hinders the activity of the 
enzyme. As with the other mutations in the cap, the crystal structure of the closed-
conformation of NtdB would validate this assumption. 
 
Δ
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Figure 4.23: Hydrolysis of K6P catalyzed by H152F.  
Michaelis-Menten curve of H152F generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements. 
 
4.9 Prevalence of NtdB-like enzymes 
NtdB’s unique feature compared to other phosphatases in the HAD superfamily is 
the presence of a long specificity loop in the cap domain, which contains amino acid 
residues that are important for the binding of K6P. A search in GenBank
®
 was performed 
to evaluate whether or not this specificity loop was common in phosphatases of other 
organisms (Figure 4.24).
68
 
 
This research has revealed that in bacteria, many amino acid sequences from 
putative phosphatases have been found containing this specificity loop (Figure 4.24). Of 
these, the overall amino acid sequences of members of the Bacillus genus are more than 
70% similar compared to NtdB from Bacillus subtilis, while other organisms are more 
than 50% similar, regardless of the phylum they belong to. K6P hydrolysis may be a 
common phenomenon in the bacterial kingdom.  
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Figure 4.24: Sequence alignment of the specificity loop of NtdB with other proteins.  
Generated with ClustalW
20
, using the Blosum scoring matrix
21
: opening gap penality = 10; extending gap 
penality = 0.20; distance gap penality = 5. Image was created by ESPript V2.2
22
. The amino acids 
represented with white letters are identical, while red letters denote similar residues. 
 
  
 As can be seen in Figure 4.24, two aspartic residues are strictly conserved among 
all species and correspond to D193 and D199 in NtdB. In the last section, these amino 
acids were shown to be necessary for the enzyme to recognize K6P as a substrate. D199 
was proposed to play a central role in substrate recognition, while D193 may be a key 
player in the closed-conformation of the enzyme. It is proposed that the presence of this 
long specificity loop in the cap domain, containing two conserved aspartic acid residues, 
is a feature of enzymes catalyzing the dephosphorylation of K6P. To test this hypothesis, 
KabB, which has been proposed to be involved in kanosamine biosynthesis,
23
 was 
investigated.  
 
 
 
NtdB 
KabB 
 74 
 
4.10 Homology modeling of KabB 
 
Comparative modeling allows for generation of a structural model of a target protein, 
based on the comparison with a similar protein of known structure. The high amino acid 
sequence similarity between NtdB and KabB suggests that both proteins have similar 
secondary structures. Using SWISS-MODEL
71-73
, Figure 4.25 shows no difference 
between the secondary structures of NtdB and KabB, which is in accordance with CD 
experiments (§4.14). The accuracy of this model was calculated to be 73% (as defined by 
equivalent C positions).  
 
 
Figure 4.25: The comparison between NTD and the proposed crystal structure of KabB.  
NtdB is represented in green (PDB 3GYG) and KabB in orange.  
 
 The active site residues in the core domain are similar in orientation between the 
proposed KabB model and NtdB (Figure 4.26). In the region of the substrate binding site 
located in the cap domain, the main differences in the orientation of the amino acids are 
R149 in NtdB, and K154 in KabB (Figure 4.27). In NtdB, R149K did not significantly 
affect the activity of the enzyme.    
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Figure 4.26: The comparison between NTD and the proposed location of the amino acid residue of 
KabB in the active site.  
NtdB is represented in green (PDB 3GYG) and KabB in orange. 
 
 
Figure 4.27: The comparison between NTD and the proposed location of the amino acid residue of 
KabB in the substrate binding site.  
NtdB is represented in green (PDB 3GYG) and KabB in orange. 
 
 
  Homology modeling of KabB suggests that KabB possesses the structural 
characteristics of a phosphatase. In its core domain, a Rossmann-like fold is present, as 
K209 
K214 
D232 
D237 
D27 
D31 
T65 
T69 
D25 
D29 
D236 
D241 
D196 
N201 
C187 
C192 
D193 
D198 
K154 
R149  
H152 
F157 D199 
D204 
D201 
D206 
 76 
 
well as a β-hairpin. The cap domain not only resembles the Cof hydrolase family, with its 
three β-strands, but also contains the unusually long loop characteristic of NtdB. This 
model does not suggest any differences between the structure of NtdB and KabB. 
 
4.11 Sub-cloning kabB 
 
According to BLAST
45
 and SWISS-MODEL,
71-73
 NtdB contains an amino acid 
sequence identity of 55% with KabB (Figure 1.3) and it was believed that the 
comparison of the kinetic behavior of both enzymes with K6P would reveal a strong 
similarity. To perform such a comparison, the kabB gene was obtained from the kab 
operon in the pET-22b-kabABC construct. 
  
First, the kabB gene needed to be isolated and subcloned into another vector. The 
vector pET-28b was selected as it was the same plasmid used for NtdB. Therefore, a 
similar construct from the same plasmid would be obtained, which allows for a direct 
comparison.  
 
The restriction sites used to introduce the kabB gene in the vector were NdeI and 
BamHI (Figure 4.28). DNA sequencing confirmed successful sub-cloning of kabB. 
 
 
Figure 4.28: Vector map of kabB in pET-28b using unique restriction sites BamHI and NdeI. 
Figure generated using NEBcutter v2.0.
70
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4.12 Purification WT KabB and mutant 
 
The successful purification of WT KabB can be observed in Figure 4.29.  
 
 
Figure 4.29: SDS-PAGE of pure WT KabB. 
Lane 1: Crude WT KabB. Lane 2: Flow-through. Lane 3: Wash. Lane 4: Eluted WT KabB. Lane 5: Empty. 
Lane 6: Ladder. 
 
 The calculated molecular weight of KabB was 34 824 Da, and the apparent 
molecular weight on the SDS-PAGE reflects this value. The KabB N201D mutation was 
also successful and resulted in an apparent molecular weight similar to WT KabB 
(Figure 4.30). 
 
 
Figure 4.30: SDS-PAGE of pure KabB N201D.  
Lane 1: Ladder. Lane 2: WT NtdB. Lane 3: WT KabB. Lane 4: N201D. 
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The difference between the apparent molecular weight of NtdB by SDS-PAGE and 
KabB is the first indication that KabB and NtdB, in spite of their high amino acid 
sequence identity, may have different characteristics. This was further observed in the 
kinetics with K6P. 
 
4.13 Kinetics of KabB 
Kinetics were performed on KabB using the EnzChek
® 
phosphate assay (Figure 
4.31) and compared with WT NtdB (Table 4.9). 
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Figure 4.31: Hydrolysis of K6P catalyzed by WT KabB.  
Michaelis-Menten curve of WT KabB generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements. 
 
Table 4.9: Comparison of the kinetic values of NtdB, KabB, and KabB N201D. 
Enzyme 
Vmax  
(nM s
-1
) 
Km  
(µM) 
kcat  
(s
-1
) 
kcat / Km  
(M
-1
s
-1
) 
NtdB 800 ± 20 93 ± 7 32 ± 3 (3.4 ± 0.4) x 10
5
 
KabB 106 ± 3 500 ± 50 0.42 ± 0.04 (8.5 ± 1.0) x 10
2
 
N201D 142 ± 7 570 ± 60 0.57 ± 0.06 (8.8 ± 1.0) x 10
2
 
 
 Because of the strong amino acid sequence similarity between KabB and NtdB, it 
was expected that both enzymes would present similar kinetic results with K6P. However 
Δ
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this was not the case. The Km of KabB was 5 times higher than that of NtdB, while the 
activity of KabB was 1.3% of NtdB. 
  
Analysis of specificity loop sequences of both enzymes (Figures 1.3 and 4.24, 
NtdB amino acids R186-I203, KabB residues K191-I208) reveals only three amino acid 
differences: K191, N201 and C202 (equivalent to R186, D196, and S197 in NtdB). The 
first amino acid difference, arginine/lysine contains the same positive charge and was not 
expected to create much impact since its location is far from the substrate binding site. 
The D196N mutation was also performed in NtdB (§4.8.2) and the change in kinetics 
were not comparable to what was observed with KabB. Nevertheless, the mutation of this 
amino acid was also performed in KabB, N201D, and results indicate that the mutation 
slightly increases the activity KabB with K6P, but the Km still remains much higher than 
with NtdB (Figure 4.32). This confirms that the presence of an aspartic acid at this 
position of the substrate binding site of NtdB contributes to catalysis with K6P but still 
does not account for the notable difference in the kinetics between NtdB and KabB. 
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Figure 4.32: Hydrolysis of K6P catalyzed by KabB N201D.  
Michaelis-Menten curve of N201D generated by Sigma Plot 11.0, using the EnzChek
®
 Phosphate assay. 
Each point represents at least two measurements. 
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The third amino acid difference in the specificity loop corresponds to C202 in 
KabB, and S197 in NtdB. The presence of this cysteine may affect the substrate binding 
site of the enzyme if a disulfide bridge is formed with another cysteine residue. C192 in 
KabB (C187 in NtdB) may be a good candidate for the formation of a disulfide bond with 
C202. In the crystal structure of NtdB, the corresponding amino acids, S197 and C187, 
are 5.3 Å apart from each other (Figure 4.33) and seem to form a dihedral angle around 
90°, which is an angle favored for the formation of disulfide bonds.
97
 So, if S197 was 
replaced by a cysteine residue, a disulfide bond may occur. The mutation of C187 to 
alanine in NtdB did have a strong impact on the activity and the specificity of the enzyme 
(§4.8.4). The formation of a disulfide bond in KabB would prevent this residue from 
performing its proposed structural role.  Further investigation of C202 in KabB, such as a 
mutation to serine, would be required in the future to test the hypothesis that this amino 
acid difference between KabB and NtdB contributes for the difference in activity seen 
with K6P. 
 
 
Figure 4.33: Distance between the cysteine residue and the serine residue in WT NtdB 
 
On a neighboring loop, the mutation R149K in NtdB showed no change, while 
H152F increased the activity of the enzyme (Table 4.7). These amino acids correspond to 
K154 and F157 respectively in KabB. Therefore, these changes in the amino acid 
sequence could not be responsible for the difference observed in KabB.  The difference 
from histidine to phenylalanine could have suggested that KabB would work even better 
C187 
S197 
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than NtdB in the presence of K6P, however this was not observed. Therefore, another 
factor must be interfering. 
 
In the core domain, the four motifs are also strictly conserved in KabB, as well as 
most amino acids around them. If the lower activity of KabB compared to NtdB is not 
due to the presence of the cysteine residue C202 in the substrate specificity loop, it could 
be due to an improper closing of the protein. The crystal structure of KabB would then be 
needed to compare minor structural difference with NtdB.    
 
It is possible that K6P is not the native substrate of KabB. To start testing this 
hypothesis, kinetics were performed with G6P, GlcAm6P, NTD-6'-phosphate and para-
nitrophenylphosphate. None of these substrates showed detectable activity with KabB. 
Other substrates would need to be tested in the future, such as NDP-kanosamine. 
 
4.14 Circular dichroism 
 
 
Circular dichroism (CD) is a useful tool to determine if a mutation causes any 
significant changes in the structure of a protein. It uses the optical property of the 
backbone of proteins, which is absorbing left and right circularly polarized light in an 
unequal amount. Depending on the secondary structure of the protein, this gives rise to 
different spectra.
98,99
 This electronic absorption property can be measured by CD and can 
be used to evaluate the changes in the secondary structure of the protein in different 
conditions.
100
 Based on previous studies of proteins with unique secondary structure, α-
helices are expected to produce negative peaks at 208 nm and 222 nm and a positive peak 
at 193 nm
101, β-antiparallel sheets show negative peak at 218 nm and positive peak at 195 
nm
102
, and disordered proteins contain a negative peak at 195 nm and positive peak at 
210 nm.
103
 A protein spectrum is therefore the sum of the peaks created by the amounts 
of different secondary structures.    
 
Because some amino acids may be instrumental in the formation of an α-helix or β-
strand, or in the prevention of such secondary structures, a mutation in certain amino acid 
 82 
 
can cause the protein to precipitate, unfold or lose some of its structural properties, which 
can be measured by CD.   
 
Since mutations were introduced into NtdB and KabB to evaluate the effect of 
selected amino acid residues on the activity of the enzyme and not on the secondary 
structure, CD spectra of NtdB and each mutant were collected and compared to the WT 
to verify the conservation of secondary structure. The results are normalized to account 
for difference in concentration as shown in Figure 4.34.  
 
 
Figure 4.34: Comparing CD spectra of KabB, NtdB, and mutants.  
[θ] corresponds to the molar ellipticity.  
 
Comparing the format and shape of a curve can be subjective to the observer. 
Comparison of the spectrum can therefore be performed by analyzing the secondary 
structure of a protein by numerous software programs, which make use of database of 
known secondary structure of proteins. These programs deconvolute the CD spectra and 
calculate percentages of each secondary structure, which can then be compared. 
Comparing the validity of these softwares is beyond the scope of this thesis and since 
CDNN
77
 was chosen by the SSSC at the University of Saskatchewan, in Saskatoon, it 
was selected for this thesis. Table 4.10 shows the analysis obtained for the WT NtdB and 
its mutants using a simple basis set between 200-260 nm.   
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Table 4.10: Comparison of the percent content of secondary structures for NtdB and its mutants  
Mutant 
 
Concentration 
(mg/mL) 
α-helices 
( %) 
β-antiparallel 
( %) 
β-parallel 
( %) 
β-turn 
( %) 
Random 
( %) 
Total 
( %) 
WT NtdB 0.46 29 11 9.2 18 31 98 
D25N 0.54 30 10 9.0 18 31 98 
D27A 0.48 29 11 9.2 18 31 98 
D27N 0.52 30 10 9.0 18 31 98 
T65A 0.49 29 11 9.4 18 32 99 
T65S 0.50 30 10 9.0 18 31 98 
R149K 0.50 29 11 9.2 18 31 98 
H152F 0.47 28 11 9.3 18 31 98 
C187A 0.58 30 10 9.0 18 31 98 
D193N 0.37 29 11 9.0 18 30 97 
D196N 0.42 29 10 9.2 18 32 98 
D199N 0.51 29 11 9.1 18 31 98 
D201N 0.50 29 11 9.1 18 31 98 
K209E 0.47 29 11 9.2 18 31 98 
K209R 0.50 29 11 9.1 18 31 98 
D232A 0.55 29 11 9.3 18 32 99 
D236A 0.55 29 11 9.2 18 31 98 
WT KabB 0.53 30 10 9.1 18 31 98 
KabB N201D 0.56 30 10 9.0 18 31 98 
 
There is no more than 1% difference between the content of the principal secondary 
structures, such as the α-helices and antiparallel β-sheets, of the WT and all the mutants. 
The commonly accepted error of the analysis of the CDNN software is 1%-5%.
77
 Since 
the values obtained are within this margin, it was concluded that the selected amino acid 
mutations did not notably affect the secondary structure of NtdB and therefore, any 
observed change in behavior in the enzyme, such as loss or increase in activity, 
corresponds to the mutation itself. The same can be said about the KabB N201D mutation 
which made no significant difference in the structure of the enzyme.   
 
CD was also used to compare the secondary structure of KabB and NtdB (Figure 
4.34 and Table 4.10). Because KabB and NtdB are 55% identical, it was expected that 
the secondary structure of both enzymes would be similar. This was the case and, until a 
crystal structure of KabB is revealed, it is proposed that any differences observed 
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between both enzymes came from their 45% difference in the amino acid sequence which 
may affect the closed-conformation of the protein or the identity of the native substrate.  
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5 SUMMARY AND CONCLUSIONS 
 
The objectives of this research were to purify and characterize the activity and 
substrate selectivity of NtdB, to investigate the role of proposed active-site residues by 
site-directed mutagenesis, and to initiate an investigation of KabB, an NtdB homolog. 
 
NtdB was successfully purified. The function of NtdB was identified as a K6P 
phosphatase. NtdB does not have a role similar to trehalose-6-phosphate phosphatase 
(TPP) since it shows no activity in the presence of phosphorylated analogs of NTD. NtdB 
showed no activity with G6P or K1P which indicates the importance of the location of 
the amino and phosphate group for substrate recognition. NtdB exhibited a high level of 
activity in the presence of K6P, suggesting that it is the native substrate. 
 
Site-directed mutagenesis supported the proposed catalytic mechanism and the 
importance of the catalytic motif in the core domain of the enzyme was confirmed. 
Essential amino acids of the cap were identified. The mutations of H152, C187, D193, 
D199, and D201 changed the activity of the enzyme. Mutations of D199 and D201 
changed the substrate specificity of the enzyme. 
 
The kinetic constants of NtdB-catalyzed K6P hydrolysis by wild-type and mutant 
proteins were obtained. For the WT, Km and kcat are 93 ± 7 µM, and 32 ± 3 s
-1
, 
respectively, while kcat/Km is (3.4 ± 0.4) x 10
5
 M
-1
s
-1
 under the conditions of the 
experiments. These numbers identifies NtdB as a K6P phosphatase. 
 
KabB was successfully sub-cloned, expressed and purified. The kinetic constants 
of KabB with K6P were obtained: Km, and kcat are 500 ± 50 µM, and 0.42 ± 0.04 s
-1
, 
respectively, while kcat/Km is (8.5 ± 1.0) x 10
2
 M
-1
s
-1
. KabB and NtdB have notably 
different kinetics constants. 
 
NtdB is part of an operon that was previously reported to produce NTD. Based on 
the results obtained, the end product of the ntd operon is kanosamine, which is created by 
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a novel biosynthetic pathway. Each enzyme of this pathway requires new Enzyme 
Commission (EC) numbers because the each catalyzes novel reactions, not observed 
before. The dephosphorylation of K6P has not been reported before. Since the initial 
hypothesis was that the operon produces NTD, this would lead to the conclusion that 
other enzyme(s) are required to achieve this product, enzymes found in E. coli and B. 
subtilis, but not in B. cereus. The next step would be the investigation of these bacterial 
species to identify such enzyme(s). The identification of a novel kanosamine pathway 
will be useful to other researchers investigating the origin of aminoglycoside antibiotics, 
who can look for this or similar pathways in other organisms. 
  
 87 
 
6 REFERENCES 
 
1. Numata, K.; Yamamoto, H.; Hatori, M.; Miyaki, T.; Kawaguchi, H., Isolation Of 
An Aminoglycoside Hypersensitive Mutant And Its Application In Screening. 
Journal of Antibiotics 1986, 39 (7), 994-1000. 
2. Tsuno, T.; Ikeda, C.; Numata, K.; Tomita, K.; Konishi, M.; Kawaguchi, H., 3,3'-
Neotrehalosadiamine (BMY-28251), A New Aminosugar Antibiotic. Journal of 
Antibiotics 1986, 39 (7), 1001-1003. 
3. Dumitrescu, O.; Dauwalder, O.; Boisset, S.; Reverdy, M.-E.; Tristan, A.; 
Vandenesch, F., Staphylococcus aureus resistance to antibiotics: key points in 
2010. M S-Medecine Sciences 2010, 26 (11), 943-949. 
4. Holden, M. T. G.; Lindsay, J. A.; Corton, C.; Quail, M. A.; Cockfield, J. D.; 
Pathak, S.; Batra, R.; Parkhill, J.; Bentley, S. D.; Edgeworth, J. D., Genome 
Sequence of a Recently Emerged, Highly Transmissible, Multi-Antibiotic- and 
Antiseptic-Resistant Variant of Methicillin-Resistant Staphylococcus aureus, 
Sequence Type 239 (TW). Journal of Bacteriology 2010, 192 (3), 888-892. 
5. Bratu, S.; Landman, D.; Haag, R.; Recco, R.; Eramo, A.; Alam, M.; Quale, J., 
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City - 
A new threat to our antibiotic armamentarium. Archives of Internal Medicine 
2005, 165 (12), 1430-1435. 
6. Leavitt, A.; Navon-Venezia, S.; Chmelnitsky, I.; Schwaber, M. J.; Carmeli, Y., 
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae 
strains in an Israeli hospital. Antimicrobial Agents and Chemotherapy 2007, 51 
(8), 3026-3029. 
7. Numata, K. I.; Satoh, F.; Hatori, M.; Miyaki, T.; Kawaguchi, H., Isolation Of 3,3'-
Neotrehalosadiamine (Bmy-28251) From A Butirosin-Producing Organism. 
Journal of Antibiotics 1986, 39 (9), 1346-1348. 
8. Inaoka, T.; Takahashi, K.; Yada, H.; Yoshida, M.; Ochi, K., RNA Polymerase 
Mutation Activates The Production Of A Dormant Antibiotic 3,3'-
Neotrehalosadiamine Via An Autoinduction Mechanism In Bacillus Subtilis. 
Journal of Biological Chemistry 2004, 279 (5), 3885-3892. 
9. Milner, J. L.; SiloSuh, L.; Lee, J. C.; He, H. Y.; Clardy, J.; Handelsman, J., 
Production of kanosamine by Bacillus cereus UW85. Applied and Environmental 
Microbiology 1996, 62 (8), 3061-3065. 
10. Janiak, A. M.; Milewski, S., Mechanism of antifungal action of kanosamine. 
Medical Mycology 2001, 39 (5), 401-408. 
 88 
 
11. Iwai, Y.; Tanaka, H.; Oiwa, R.; Shimizu, S.; Omura, S., Studies On Bacterial-Cell 
Wall Inhibitors .3. 3-Amino-3-Deoxy-D-Glucose, An Inhibitor Of Bacterial-Cell 
Wall Synthesis. Biochimica Et Biophysica Acta 1977, 498 (1), 223-228. 
12. Fusetani, N.; Ejima, D.; Matsunaga, S.; Hashimoto, K.; Itagaki, K.; Akagi, Y.; 
Taga, N.; Suzuki, K., 3-Amino-3-Deoxy-D-Glucose - An Antibiotic Produced By 
A Deep-Sea Bacterium. Experientia 1987, 43 (4), 464-465. 
13. Dolak, L. A.; Castle, T. M.; Laborde, A. L., 3-Trehalosamine, A New 
Disaccharide Antibiotic. Journal of Antibiotics 1980, 33 (7), 690-694. 
14. Inaoka, T.; Ochi, K., Glucose uptake pathway-specific regulation of synthesis of 
neotrehalosadiamine, a novel autoinducer produced in Bacillus subtilis. Journal of 
Bacteriology 2007, 189 (1), 65-75. 
15. Langill, D. M. Synthesis of neotrehalose; kinetics and mutagenesis of NtdC. 
University of Saskatchewan, Saskatoon, SK, 2010. 
16. van Straaten, K. E.; Langill, D. M.; Palmer, D. R. J.; Sanders, D. A. R., 
Purification, crystallization and preliminary X-ray analysis of NtdA, a putative 
pyridoxal phosphate-dependent aminotransferase from Bacillus subtilis. Acta 
Crystallographica Section F-Structural Biology and Crystallization 
Communications 2009, 65, 426-429. 
17. Vetter, N. D.; Palmer, D. R. J., Unpublished results: 2012. 
18. van Straaten, K. E.; Langill, D. M.; Palmer, D. R. J.; Sanders, To be published, 
2012. 
19. Elbein, A. D.; Pan, Y. T.; Pastuszak, I.; Carroll, D., New insights on trehalose: a 
multifunctional molecule. Glycobiology 2003, 13 (4), 17R-27R. 
20. Thompson, J. D.; Higgins, D. G.; Gibson, T. J., Clustal-W - Improving The 
Sensitivity Of Progressive Multiple Sequence Alignment Through Sequence 
Weighting, Position-Specific Gap Penalties And Weight Matrix Choice. Nucleic 
Acids Research 1994, 22 (22), 4673-4680. 
21. Henikoff, S.; Henikoff, J. G., Amino-Acid Substitution Matrices From Protein 
Blocks. Proceedings of the National Academy of Sciences of the United States of 
America 1992, 89 (22), 10915-10919. 
22. Gouet, P.; Courcelle, E.; Stuart, D. I.; Metoz, F., ESPript: analysis of multiple 
sequence alignments in PostScript. Bioinformatics 1999, 15 (4), 305-308. 
23. Kevany, B. M.; Rasko, D. A.; Thomas, M. G., Characterization of the Complete 
Zwittermicin A Biosynthesis Gene Cluster from Bacillus cereus. Applied and 
Environmental Microbiology 2009, 75 (4), 1144-1155. 
 89 
 
24. Guo, J. T.; Frost, J. W., Kanosamine biosynthesis: A likely source of the 
aminoshikimate pathway's nitrogen atom. Journal of the American Chemical 
Society 2002, 124 (36), 10642-10643. 
25. Engels, S. Sugars in early and late polyketide biosynthesis: Functional studies of 
rifL, rifK and rifM in rifamycin biosynthesis; Towards the characterisation of a 
PKS gene cluster from Streptomyces sp. GW2/5831, encoding the biosynthesis of 
the polycyclic xanthone IB-00208. University of Bonn, University of Bonn, 2009. 
26. Arakawa, K.; Muller, R.; Mahmud, T.; Yu, T. W.; Floss, H. G., Characterization 
of the early stage aminoshikimate pathway in the formation of 3-amino-5-
hydroxybenzoic acid: The RifN protein specifically converts kanosamine into 
kanosamine 6-phosphate. Journal of the American Chemical Society 2002, 124 
(36), 10644-10645. 
27. Westheimer, F. H., Why Nature Chose Phosphates. Science 1987, 235 (4793), 
1173-1178. 
28. Florian, J.; Warshel, A., Phosphate ester hydrolysis in aqueous solution: 
Associative versus dissociative mechanisms. Journal of Physical Chemistry B 
1998, 102 (4), 719-734. 
29. Florian, J.; Warshel, A., A fundamental assumption about OH- attack in 
phosphate ester hydrolysis is not fully justified. Journal of the American 
Chemical Society 1997, 119 (23), 5473-5474. 
30. Lad, C.; Williams, N. H.; Wolfenden, R., The rate of hydrolysis of 
phosphomonoester dianions and the exceptional catalytic proficiencies of protein 
and inositol phosphatases. Proceedings of the National Academy of Sciences of 
the United States of America 2003, 100 (10), 5607-5610. 
31. Wolfenden, R.; Snider, M. J., The depth of chemical time and the power of 
enzymes as catalysts. Accounts of Chemical Research 2001, 34 (12), 938-945. 
32. Rusnak, F.; Mertz, P., Calcineurin: Form and function. Physiological Reviews 
2000, 80 (4), 1483-1521. 
33. Schenk, G.; Boutchard, C. L.; Carrington, L. E.; Noble, C. J.; Moubaraki, B.; 
Murray, K. S.; de Jersey, J.; Hanson, G. R.; Hamilton, S., A purple acid 
phosphatase from sweet potato contains an antiferromagnetically coupled 
binuclear Fe-Mn center. Journal of Biological Chemistry 2001, 276 (22), 19084-
19088. 
34. Egloff, M. P.; Cohen, P. T. W.; Reinemer, P.; Barford, D., Crystal-Structure Of 
The Catalytic Subunit Of Human Protein Phosphatase-1 And Its Complex With 
Tungstate. Journal of Molecular Biology 1995, 254 (5), 942-959. 
 90 
 
35. Shi, Y., Serine/Threonine Phosphatases: Mechanism through Structure. Cell 2009, 
139 (3), 468-484. 
36. Changela, A.; Ho, C. K.; Martins, A.; Shuman, S.; Mondragon, A., Structure and 
mechanism of the RNA triphosphatase component of mammalian mRNA capping 
enzyme. Embo Journal 2001, 20 (10), 2575-2586. 
37. McCain, D. F.; Catrina, I. E.; Hengge, A. C.; Zhang, Z. Y., The catalytic 
mechanism of Cdc25A phosphatase. Journal of Biological Chemistry 2002, 277 
(13), 11190-11200. 
38. Baker, A. S.; Ciocci, M. J.; Metcalf, W. W.; Kim, J.; Babbitt, P. C.; Wanner, B. 
L.; Martin, B. M.; Dunaway-Mariano, D., Insights into the mechanism of catalysis 
by the P-C bond-cleaving enzyme phosphonoacetaldehyde hydrolase derived 
from gene sequence analysis and mutagenesis. Biochemistry 1998, 37 (26), 9305-
9315. 
39. Wang, W. Q.; Sun, J. P.; Zhang, Z. Y., An overview of the protein tyrosine 
phosphatase superfamily. Current Topics in Medicinal Chemistry 2003, 3 (7), 
739-748. 
40. Stec, B.; Holtz, K. M.; Kantrowitz, E. R., A revised mechanism for the alkaline 
phosphatase reaction involving three metal ions. Journal of Molecular Biology 
2000, 299 (5), 1303-1311. 
41. de Backer, M.; McSweeney, S.; Rasmussen, H. B.; Riise, B. W.; Lindley, P.; 
Hough, E., The 1.9 angstrom crystal structure of heat-labile shrimp alkaline 
phosphatase. Journal of Molecular Biology 2002, 318 (5), 1265-1274. 
42. Ostanin, K.; Harms, E. H.; Stevis, P. E.; Kuciel, R.; Zhou, M. M.; Vanetten, R. L., 
Overexpression, Site-Directed Mutagenesis, And Mechanism Of Escherichia-Coli 
Acid-Phosphatase. Journal of Biological Chemistry 1992, 267 (32), 22830-22836. 
43. Ghosh, A.; Shieh, J. J.; Pan, C. J.; Sun, M. S.; Chou, J. Y., The catalytic center of 
glucose-6-phosphatase - HIS176 is the nucleophile forming the phosphohistidine-
enzyme intermediate during catalysis. Journal of Biological Chemistry 2002, 277 
(36), 32837-32842. 
44. Burroughs, A. M.; Allen, K. N.; Dunaway-Mariano, D.; Aravind, L., Evolutionary 
genomics of the HAD superfamily: Understanding the structural adaptations and 
catalytic diversity in a superfamily of phosphoesterases and allied enzymes. 
Journal of Molecular Biology 2006, 361 (5), 1003-1034. 
45. Altschul, S. F.; Madden, T. L.; Schaffer, A. A.; Zhang, J. H.; Zhang, Z.; Miller, 
W.; Lipman, D. J., Gapped BLAST and PSI-BLAST: a new generation of protein 
database search programs. Nucleic Acids Research 1997, 25 (17), 3389-3402. 
 91 
 
46. Koonin, E. V.; Tatusov, R. L., Computer-Analysis Of Bacterial Haloacid 
Dehalogenases Defines A Large Superfamily Of Hydrolases With Diverse 
Specificity - Application Of An Iterative Approach To Database Search. Journal 
of Molecular Biology 1994, 244 (1), 125-132. 
47. Nocek, B.; Stein, A.; Wu, R.; Jedrzejczak, R.; Joachimiak, A., Crystal structure of 
yhjK (haloacid dehalogenase-like hydrolase protein) from Bacillus subtilis. 2009. 
48. Rao, S. T.; Rossmann, M. G., Comparison Of Super-Secondary Structures In 
Proteins. Journal of Molecular Biology 1973, 76 (2), 241-&. 
49. Kleiger, G.; Eisenberg, D., GXXXG and GXXXA motifs stabilize FAD and 
NAD(P)-binding Rossmann folds through C-alpha-H center dot center dot center 
dot O hydrogen bonds and van der Waals interactions. Journal of Molecular 
Biology 2002, 323 (1), 69-76. 
50. Brakoulias, A.; Jackson, R. M., Towards a structural classification of phosphate 
binding sites in protein-nucleotide complexes: An automated all-against-all 
structural comparison using geometric matching. Proteins-Structure Function and 
Bioinformatics 2004, 56 (2), 250-260. 
51. Fieulaine, S.; Lunn, J. E.; Borel, F.; Ferrer, J. L., The structure of a cyanobacterial 
sucrose-phosphatase reveals the sugar tongs that release free sucrose in the cell. 
Plant Cell 2005, 17 (7), 2049-2058. 
52. Regni, C.; Tipton, P. A.; Beamer, L. J., Crystal structure of PMM/PGM: An 
enzyme in the biosynthetic pathway of P-aeruginosa virulence factors. Structure 
2002, 10 (2), 269-279. 
53. Rao, K. N.; Kumaran, D.; Seetharaman, J.; Bonanno, J. B.; Burley, S. K.; 
Swaminathan, S., Crystal structure of trehalose-6-phosphate phosphatase-related 
protein: Biochemical and biological implications. Protein Science 2006, 15 (7), 
1735-1744. 
54. Kawamura, T.; Watanabe, N.; Tanaka, I., Structure of mannosyl-3-
phosphoglycerate phosphatase from Pyrococcus horikoshii. Acta 
Crystallographica Section D-Biological Crystallography 2008, 64, 1267-1276. 
55. Aravind, L.; Galperin, M. Y.; Koonin, E. V., The catalytic domain of the P-type 
ATPase has the haloacid dehalogenase fold. Trends in Biochemical Sciences 
1998, 23 (4), 127-129. 
56. Seal, S. N.; Rose, Z. B., Characterization Of A Phosphoenzyme Intermediate In 
The Reaction Of Phosphoglycolate Phosphatase. Journal of Biological Chemistry 
1987, 262 (28), 13496-13500. 
 92 
 
57. Collet, J. F.; Gerin, I.; Rider, M. H.; VeigadaCunha, M.; VanSchaftingen, E., 
Human L-3-phosphoserine phosphatase: Sequence, expression and evidence for a 
phosphoenzyme intermediate. Febs Letters 1997, 408 (3), 281-284. 
58. Collet, J. F.; Stroobant, V.; Van Schaftingen, E., Mechanistic studies of 
phosphoserine phosphatase, an enzyme related to P-type ATPases. Journal of 
Biological Chemistry 1999, 274 (48), 33985-33990. 
59. Cronin, A.; Homburg, S.; Duerk, H.; Richter, I.; Adamskal, M.; Frere, F.; Arand, 
M., Insights into the Catalytic Mechanism of Human sEH Phosphatase by Site-
Directed Mutagenesis and LC-MS/MS Analysis. Journal of Molecular Biology 
2008, 383 (3), 627-640. 
60. Lahiri, S. D.; Zhang, G. F.; Dunaway-Mariano, D.; Allen, K. N., Caught in the 
act: The structure of phosphorylated beta-phosphoglucomutase from Lactococcus 
lactis. Biochemistry 2002, 41 (26), 8351-8359. 
61. Morais, M. C.; Zhang, W. H.; Baker, A. S.; Zhang, G. F.; Dunaway-Mariano, D.; 
Allen, K. N., The crystal structure of Bacillus cereus phosphonoacetaldehyde 
hydrolase: Insight into catalysis of phosphorus bond cleavage and catalytic 
diversification within the HAD enzyme superfamily. Biochemistry 2000, 39 (34), 
10385-10396. 
62. Wang, W. R.; Kim, R.; Jancarik, J.; Yokota, H.; Kim, S. H., Crystal structure of 
phosphoserine phosphatase from Methanococcus jannaschii, a hyperthermophile, 
at 1.8 angstrom resolution. Structure 2001, 9 (1), 65-71. 
63. Rinaldo-Matthis, A.; Rampazzo, C.; Reichard, P.; Bianchi, V.; Nordlund, P., 
Crystal structure of a human mitochondrial deoxyribonucleotidase. Nature 
Structural Biology 2002, 9 (10), 779-787. 
64. Kim, Y. C.; Yakunin, A. F.; Kuznetsova, E.; Xu, X. H.; Pennycooke, M.; Gu, J.; 
Cheung, F.; Proudfoot, M.; Arrowsmith, C. H.; Joachimiak, A.; Edwards, A. M.; 
Christendat, D., Structure- and function-based characterization of a new 
phosphoglycolate phosphatase from Thermoplasma acidophilum. Journal of 
Biological Chemistry 2004, 279 (1), 517-526. 
65. Lu, Z. B.; Dunaway-Mariano, D.; Allen, K. N., HAD superfarnily 
phosphotransferase substrate diversification: Structure and function analysis of 
HAD subclass IIB sugar phosphatase BT4131. Biochemistry 2005, 44 (24), 8684-
8696. 
66. Lahiri, S. D.; Zhang, G. F.; Dai, J. Y.; Dunaway-Mariano, D.; Allen, K. N., 
Analysis of the substrate specificity loop of the HAD superfamily cap domain. 
Biochemistry 2004, 43 (10), 2812-2820. 
67. Omene, E.; Vetter, N.; Palmer, D. R. J., Unpublished results: 2010. 
 93 
 
68. Benson, D. A.; Cavanaugh, M.; Clark, K.; Karsch-Mizrachi, I.; Lipman, D. J.; 
Ostell, J.; Sayers, E. W., GenBank. Nucleic Acids Research 2013, 41 (D1), D36-
D42. 
69. Kibbe, W. A., OligoCalc: an online oligonucleotide properties calculator. Nucleic 
Acids Research 2007, 35, W43-W46. 
70. Vincze, T.; Posfai, J.; Roberts, R. J., NEBcutter: a program to cleave DNA with 
restriction enzymes. Nucleic Acids Research 2003, 31 (13), 3688-3691. 
71. Guex, N.; Peitsch, M. C., SWISS-MODEL and the Swiss-PdbViewer: An 
environment for comparative protein modeling. Electrophoresis 1997, 18 (15), 
2714-2723. 
72. Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T., The SWISS-MODEL workspace: 
a web-based environment for protein structure homology modelling. 
Bioinformatics 2006, 22 (2), 195-201. 
73. Schwede, T.; Kopp, J.; Guex, N.; Peitsch, M. C., SWISS-MODEL: an automated 
protein homology-modeling server. Nucleic Acids Research 2003, 31 (13), 3381-
3385. 
74. Wishart, D. S.; Knox, C.; Guo, A. C.; Eisner, R.; Young, N.; Gautam, B.; Hau, D. 
D.; Psychogios, N.; Dong, E.; Bouatra, S.; Mandal, R.; Sinelnikov, I.; Xia, J.; Jia, 
L.; Cruz, J. A.; Lim, E.; Sobsey, C. A.; Shrivastava, S.; Huang, P.; Liu, P.; Fang, 
L.; Peng, J.; Fradette, R.; Cheng, D.; Tzur, D.; Clements, M.; Lewis, A.; De 
Souza, A.; Zuniga, A.; Dawe, M.; Xiong, Y.; Clive, D.; Greiner, R.; Nazyrova, 
A.; Shaykhutdinov, R.; Li, L.; Vogel, H. J.; Forsythe, I., HMDB: a 
knowledgebase for the human metabolome. Nucleic Acids Research 2009, 37, 
D603-D610. 
75. Sambrook, J.; Russell, D. W., Molecular cloning: A laboratory manual. 2001. 
76. Johnson, W. C., Protein Secondary Structure And Circular-Dichroism - A 
Practical Guide. Proteins-Structure Function and Genetics 1990, 7 (3), 205-214. 
77. Bohm, G.; Muhr, R.; Jaenicke, R., Quantitative-Analysis Of Protein Far Uv 
Circular-Dichroism Spectra By Neural Networks. Protein Engineering 1992, 5 
(3), 191-195. 
78. Parsons, J. F.; Lim, K.; Tempczyk, A.; Krajewski, W.; Eisenstein, E.; Herzberg, 
O., From structure to function: YrbI from Haemophilus influenzae (HI1679) is a 
phosphatase. Proteins-Structure Function and Genetics 2002, 46 (4), 393-404. 
79. Harder, K. W.; Owen, P.; Wong, L. K. H.; Aebersold, R.; Clarklewis, I.; Jirik, F. 
R., Characterization And Kinetic-Analysis Of The Intracellular Domain Of 
Human-Protein-Tyrosine-Phosphatase-Beta (HPTP-Beta) Using Synthetic 
Phosphopeptides. Biochemical Journal 1994, 298, 395-401. 
 94 
 
80. Webb, M. R., A Continuous Spectrophotometric Assay For Inorganic-Phosphate 
And For Measuring Phosphate Release Kinetics In Biological-Systems. 
Proceedings of the National Academy of Sciences of the United States of America 
1992, 89 (11), 4884-4887. 
81. Weber, K.; Osborn, M., Reliability Of Molecular Weight Determinations By 
Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis. Journal of Biological 
Chemistry 1969, 244 (16), 4406-&. 
82. Dunker, A. K.; Rueckert, R. R., Observations On Molecular Weight 
Determinations On Polyacrylamide Gel. Journal of Biological Chemistry 1969, 
244 (18), 5074-&. 
83. Hirel, P. H.; Schmitter, J. M.; Dessen, P.; Fayat, G.; Blanquet, S., Extent Of N-
Terminal Methionine Excision From Escherichia-Coli Proteins Is Governed By 
The Side-Chain Length Of The Penultimate Amino-Acid. Proceedings of the 
National Academy of Sciences of the United States of America 1989, 86 (21), 
8247-8251. 
84. Tramer, J., Simple And Rapid Methods For The Estimation Of Bacterial 
Phosphatases Using Di-Sodium Para-Nitrophenylphosphate As Substrate. Journal 
of Dairy Research 1952, 19 (3), 275-287. 
85. Shin, D. H.; Roberts, A.; Jancarik, J.; Yokota, H.; Kim, R.; Wemmer, D. E.; Kim, 
S. H., Crystal structure of a phosphatase with a unique substrate binding domain 
from Thermotoga maritima. Protein Science 2003, 12 (7), 1464-1472. 
86. Soyenkoff, B., A Micromethod Of Phosphate Determination. Journal of 
Biological Chemistry 1947, 168 (2), 447-457. 
87. Baykov, A. A.; Evtushenko, O. A.; Avaeva, S. M., A Malachite Green Procedure 
For Ortho-Phosphate Determination And Its Use In Alkaline Phosphatase-Based 
Enzyme-Immunoassay. Analytical Biochemistry 1988, 171 (2), 266-270. 
88. Kormish, J. D.; McGhee, J. D., The C-elegans lethal gut-obstructed gob-1 gene is 
trehalose-6-phosphate phosphatase. Developmental Biology 2005, 287 (1), 35-47. 
89. Nelson, D. L.; Cox, M. M., Lehninger'a Principles of Biochemistry. 4th Edition 
ed.; Freeman & Co.: WH, 2004. 
90. Khersonsky, O.; Tawfik, D. S., Enzyme Promiscuity: A Mechanistic and 
Evolutionary Perspective. In Annual Review of Biochemistry, Vol 79, Kornberg, 
R. D.; Raetz, C. R. H.; Rothman, J. E.; Thorner, J. W., Eds. 2010; Vol. 79, pp 
471-505. 
91. Glasner, M. E.; Gerlt, J. A.; Babbitt, P. C., Evolution of enzyme superfamilies. 
Current Opinion in Chemical Biology 2006, 10 (5), 492-497. 
 95 
 
92. Beassoni, P. R.; Otero, L. H.; Massimelli, M. J.; Lisa, A. T.; Domenech, C. E., 
Critical active-site residues identified by site-directed mutagenesis in 
Pseudomonas aeruginosa phosphorylcholine phosphatase, a new member of the 
haloacid dehalogenases hydrolase superfamily. Current Microbiology 2006, 53 
(6), 534-539. 
93. Selengut, J. D., MDP-1 is a new and distinct member of the haloacid 
dehalogenase family of aspartate-dependent phosphohydrolases. Biochemistry 
2001, 40 (42), 12704-12711. 
94. Kurihara, T.; Liu, J. Q.; Nardidei, V.; Koshikawa, H.; Esaki, N.; Soda, K., 
Comprehensive Site-Directed Mutagenesis Of L-2-Halo Acid Dehalogenase To 
Probe Catalytic Amino-Acid-Residues. Journal of Biochemistry 1995, 117 (6), 
1317-1322. 
95. Emsley, P.; Cowtan, K., Coot: model-building tools for molecular graphics. Acta 
Crystallographica Section D-Biological Crystallography 2004, 60, 2126-2132. 
96. Barnes, M. R.; Gray, I. C., Bioinformatics for geneticists. 2003; p xiv + 408 pp.-
xiv + 408 pp. 
97. Bhattacharyya, R.; Pal, D.; Chakrabarti, P., Disulfide bonds, their stereospecific 
environment and conservation in protein structures. Protein Engineering Design 
& Selection 2004, 17 (11), 795-808. 
98. Kokke, W., Determination Of Optical Purity Using Circular-Polarization Of 
Luminescence. Journal of the American Chemical Society 1974, 96 (8), 2627-
2628. 
99. Greenfield, N. J., Using circular dichroism spectra to estimate protein secondary 
structure. Nature Protocols 2006, 1 (6), 2876-2890. 
100. Johnson, W. C., Secondary Structure Of Proteins Through Circular-Dichroism 
Spectroscopy. Annual Review of Biophysics and Biophysical Chemistry 1988, 17, 
145-166. 
101. Holzwart.G; Doty, P., Ultraviolet Circular Dichroism Of Polypeptides. Journal of 
the American Chemical Society 1965, 87 (2), 218-&. 
102. Greenfie.N; Fasman, G. D., Computed Circular Dichroism Spectra For Evaluation 
Of Protein Conformation. Biochemistry 1969, 8 (10), 4108-&. 
103. Venyaminov, S. Y.; Baikalov, I. A.; Shen, Z. M.; Wu, C. S. C.; Yang, J. T., 
Circular Dichroic Analysis Of Denatured Proteins - Inclusion Of Denatured 
Proteins In The Reference Set. Analytical Biochemistry 1993, 214 (1), 17-24. 
